Manufacturing of bridged artificial nucleoside

By using an intermediate compound and intramolecular cyclization with a base, the scpBNA synthesis is streamlined, addressing inefficiencies in conventional methods and enabling efficient production.

KR103045664B1Active Publication Date: 2026-11-06NIPPON SHOKUBAI CO LTD +1
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
KR1020247023671
Authority / Receiving Office
KR · KR
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-04-05
Filing Date
2020-03-31
Publication Date
2026-11-06
Estimated Expiration
2040-03-31

AI Technical Summary

Technical Problem

Conventional methods for manufacturing spirocyclopropylene bridge nucleic acid (scpBNA) are inefficient and require a multi-step process, making mass synthesis challenging.

Method used

The synthesis of scpBNA is optimized by introducing an intermediate compound represented by formula (I) and performing intramolecular cyclization in the presence of a base, such as an alkoxide, which reduces the number of process steps and enhances efficiency.

Benefits of technology

This method allows for the efficient production of scpBNA, eliminating the need for stereochemical inversion processes and simplifying the manufacturing process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 112024076465716-PAT00075_ABST
    Figure 112024076465716-PAT00075_ABST
Patent Text Reader

Abstract

A method for manufacturing a compound represented by the following formula (III) is provided, using a compound represented by the following formula (I) as a raw material.
Need to check novelty before this filing date? Find Prior Art

Description

Technology Field

[0001] The present invention relates to a method for producing spirocyclopropylene bridge nucleic acid (scpBNA). More specifically, the present invention relates to a method for producing a nucleoside of scpBNA, a compound used in the method of production, and a compound obtained by the method of production. Background Technology

[0002] Recently, nucleic acid drugs have been attracting attention as molecular species for creating new drugs. Since natural nucleic acids cause problems such as being hydrolyzed by enzymes in the body, various studies are being conducted on modified nucleic acids, and for example, scpBNA has been reported to have high binding affinity for single-stranded RNA and excellent in vivo stability (Patent Document 1 and Non-Patent Documents 1-2). Prior art literature

[0003] WO2015 / 125783

[0004] Chem. Commun., 2015, Vol. 51, p.9737-9740J. Org. Chem., 2016, Vol. 81, p.11000-11008 The problem to be solved

[0005] However, it was found that manufacturing scpBNA using conventional technology required a multi-step process, and there was room for improvement in terms of manufacturing methods intended for mass synthesis.

[0006] The present invention aims to provide a novel method for preparing a spirocyclopropylene bridge nucleic acid (scpBNA) and its precursor.

[0007] In addition, the present invention aims to provide an efficient method for producing spirocyclopropylene bridge nucleic acid (scpBNA) and its precursor.

[0008] In addition, the present invention aims to provide a compound that can be used in the above-mentioned manufacturing method, etc., and a method for manufacturing the same. means of solving the problem

[0009] Accordingly, the inventors, after carefully examining the above problem, discovered that scpBNA can be efficiently synthesized by introducing an intermediate compound represented by formula (I) described below, and thus completed the present invention.

[0010] That is, the present invention relates to the following [1] to

[37] .

[0011] [1] A method for preparing a compound represented by formula (II), comprising at least a process of intramolecularly cyclizing a compound represented by formula (I).

[0012]

[0013] (during the meal,

[0014] X represents a nucleobase portion that may have one or more any substituents selected from group α, wherein group α consists of a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an alkylthio group having 1 to 5 carbon atoms, an amino group, an amino group protected by a protecting group for nucleic acid synthesis, an amino group substituted with an alkyl group having 1 to 5 carbon atoms, and a halogen atom;

[0015] R 1 and R 2Each independently comprises a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4 Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0016] R 5 ...represents a hydrogen atom; a halogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with an aryl group having 3 to 12 carbon atoms that may contain a heteroatom and may also form a branch or ring; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may contain a heteroatom; or a silyl group.

[0017]

[0018] (In the food, X, R 1 , R 2 and R 5is as stated above)

[0019] [2] The manufacturing method described in [1] above, in which intramolecular cyclization is performed in the presence of a base.

[0020] [3] The manufacturing method described in [2] above, in which the base is an alkoxide.

[0021] [4] The base R of the compound represented by formula (IV) 6 A manufacturing method described in any one of [1] to [3], further comprising a process of deprotecting to produce a compound represented by formula (I).

[0022]

[0023] (during the meal,

[0024] X represents a nucleobase portion that may have one or more any substituents selected from group α, wherein group α consists of a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an alkylthio group having 1 to 5 carbon atoms, an amino group, an amino group protected by a protecting group for nucleic acid synthesis, an amino group substituted with an alkyl group having 1 to 5 carbon atoms, and a halogen atom;

[0025] R 1 and R 2Each independently comprises a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4 Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0026] R 5 ...represents a hydrogen atom; a halogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with an aryl group having 3 to 12 carbon atoms that may contain a heteroatom and may also form a branch or ring; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may contain a heteroatom; or a silyl group;

[0027] R 6 represents the protecting group of the hydroxyl group in nucleic acid synthesis.

[0028] [5] R 6The manufacturing method described in [4] above, in which the acetyl group is present.

[0029] [6] A manufacturing method described in any one of [1] to [5], comprising a process of manufacturing a compound represented by formula (I) using a compound represented by formula (V) as a raw material.

[0030]

[0031] (during the meal,

[0032] R 1 and R 2 Each independently, a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4 Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0033] Here, the α group comprises a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an alkylthio group having 1 to 5 carbon atoms, an amino group, an amino group protected by a protecting group for nucleic acid synthesis, an amino group substituted with an alkyl group having 1 to 5 carbon atoms, and a halogen atom.

[0034] R 6 and R 7 Each is independently a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, or a phosphate group protected by a protecting group in nucleic acid synthesis, or

[0035] R 6 and R 7 ...becomes together, -C(R 8 )(R 9 )-[In the formula, R 8 and R 9 [represents, respectively, a hydrogen atom, an alkyl group having 1 to 7 carbon atoms that may be substituted with a 3 to 12 carbon atom aryl group that may contain a hydrogen atom or a heteroatom and may also form a branch or ring, or an aryl group having a 3 to 12 carbon atom aryl portion that may contain a heteroatom]

[0036] [7] R 1 and R 2 The manufacturing method described in [6] above, in which the benzyl group is present.

[0037] [8] A method for manufacturing a compound represented by formula (III), comprising a process of cyclopropanizing a compound represented by formula (II) as described above, wherein the cyclopropanizing process comprises a process of post-treating the reaction solution with ammonia.

[0038]

[0039] (In the food, X, R 1 , R 2 and R 5 is as stated above, and R 5' is R 5 Independent of and R 5 is defined identically to)

[0040] [9] X has a pyrimidine skeleton, the manufacturing method described in [8] above.

[0041]

[10] A method for preparing a compound represented by the aforementioned formula (III), comprising at least a process of converting the compound represented by the aforementioned formula (II) into a cyclopropanol in the presence of an organic acid.

[0042]

[11] X having a purine skeleton, the manufacturing method described in

[10] above.

[0043]

[12] A method for producing a compound represented by the aforementioned formula (III), comprising at least a process of intramolecularly cyclizing a compound represented by the aforementioned formula (I) to produce a compound represented by the aforementioned formula (II), and a process of cyclopropaneizing the compound represented by the aforementioned formula (II).

[0044]

[13] A manufacturing method described in

[12] comprising a process of preparing a compound represented by formula (I) by any one of [4] to [7].

[0045]

[14] A manufacturing method described in

[12] or

[13] that performs an intramolecular cyclization process by any one of the manufacturing methods described in [1] to [7] above.

[0046]

[15] A manufacturing method described in any one of

[12] to

[14] that performs a cyclopropanization process by the manufacturing method described in any one of [8] to

[11] above.

[0047]

[16] Compounds represented by the aforementioned formula (IV) (where X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-diyl group, and R 1 and R 2 ga is a benzyl group, and R 6 When is an acetyl group and

[0048] X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 , R 2 and R 6 (Except when is an acetyl group).

[0049]

[17] R 6 A compound described in

[16] above, which is an acetyl group.

[0050]

[18] A compound described in

[16] or

[17] , wherein X is a group having a uracil skeleton with a substituent or a cytosine skeleton.

[0051]

[19] A compound described in

[18] above, wherein the substituent is selected from the group consisting of a hydroxyl group and an alkyl group having 1 to 6 carbon atoms.

[0052]

[20] A compound represented by formula (IV) which is a compound selected from the following, a compound described in any one of

[16] to

[19] .

[0053]

[0054]

[21] A compound described in

[16] or

[17] above, in which X has a purine skeleton having a substituent.

[0055]

[22] A compound described in

[21] above, wherein the substituent is selected from the group consisting of a hydroxyl group, an amino group and an amino group protected by a protecting group.

[0056]

[23] A compound represented by formula (IV) which is a compound selected from the following, a compound described in any one of

[16] ,

[17] ,

[21] ,

[22] .

[0057]

[0058]

[24] Compounds represented by the aforementioned formula (I) (where X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 and R 2 When ga is a benzyl group and

[0059] X is a 2-oxo-4-amino-1,2-dihydropyrimidine-1-yl group, and R 1 and R 2 (Except when g is a hydrogen atom).

[0060]

[25] A compound described in

[24] above, in which X has a uracil skeleton with a substituent or has a cytosine skeleton.

[0061]

[26] A compound described in

[25] above, wherein the substituent is selected from the group consisting of a hydroxyl group and an alkyl group having 1 to 6 carbon atoms.

[0062]

[27] A compound represented by formula (I) which is a compound selected from the following, a compound described in any one of

[24] to

[26] .

[0063]

[0064]

[28] A compound described in

[24] above, having a purine skeleton in which X has a substituent.

[0065]

[29] A compound described in

[28] above, wherein the substituent is selected from the group consisting of a hydroxyl group, an amino group and an amino group protected by a protecting group.

[0066]

[30] A compound represented by formula (I) which is a compound selected from the following, a compound described in any one of

[24] ,

[28] ,

[29] .

[0067]

[0068]

[31] A compound represented by the aforementioned formula (II) (wherein X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-di group, and R 1 This naphthyl group, R 2 When ga is a benzyl group and

[0069] X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 This naphthyl group, R 2 (Except when g is a hydrogen atom).

[0070]

[32] A compound described in

[31] above, wherein X is a group having a uracil skeleton with a substituent or a cytosine skeleton.

[0071]

[33] A compound described in

[32] , wherein the substituent is selected from the group consisting of a hydroxyl group and an alkyl group having 1 to 6 carbon atoms.

[0072]

[34] A compound represented by formula (II) that is selected from the following compounds, a compound described in any one of

[31] to

[33] .

[0073]

[0074]

[35] A compound described in

[31] above, having a purine skeleton in which X has a substituent.

[0075]

[36] A compound described in

[35] , wherein the substituent is selected from the group consisting of a hydroxyl group, an amino group and an amino group protected by a protecting group.

[0076]

[37] A compound represented by formula (II) which is a compound selected from the following, a compound described in any one of

[31] ,

[35] ,

[36] .

[0077] Effects of the invention

[0078] According to the present invention, scpBNA can be efficiently manufactured. Specific details for implementing the invention

[0079] The present invention is characterized by using an intermediate compound represented by the formula (I) described below.

[0080] In the present invention, by using the above compound, the stereochemical inversion process of the hydroxyl group at the 2' position of the nucleoside sugar group, which is a factor in increasing the number of process steps in the prior art, becomes unnecessary, and it is presumed that the number of process steps can be reduced, thereby enabling the efficient production of scpBNA. However, the above conjecture does not limit the present invention.

[0081] First, the terms used in this specification are defined.

[0082] The “nucleate group portion” refers to all 5 to 20-membered heterocyclic groups that exhibit aromaticity and have a structure in which, in addition to hydrocarbon groups, one or more carbon atoms constituting the hydrocarbon group are substituted with heteroatoms such as nitrogen atoms, sulfur atoms, or oxygen atoms, and includes monocyclic and condensed rings. Specifically, hydrocarbon groups include, for example, benzene, naphthalene, anthracene, phenanthrene, indane, indene, tetrahydronaphtylene, biphenylene, etc. Heterocyclic groups include, for example, purine nucleotides or pyrimidine nucleotides. Any of these groups may have one or more substituents selected from the following α group. Here, purine nucleotides or pyrimidine nucleotides include bases generally known as components of nucleic acids (e.g., guanine, adenine, cytosine, thymine, uracil), and all chemical structures and their tautomers (e.g., ketoenol tautomer, iminamine tautomer) that can act as or substitute as bases of other similar nucleic acid components. In addition, thiophene, thianthren, furan, pyran, isobenzofuran, cromen, xanthen, phenoxathine, pyrrole, imidazole, pyrazol, isothiazol, isooxazole, pyridazine, indolizine, indole, isoindole, isoquinoline, quinoline, naphthiridine, quinoxaline, quinazolin, pteridine, carbazole, phenantridine, acridine, ferrimidine, phenazine, phenarzine, phenothiazine, furazane, phenoxazine, pyrrolidine, pyrroline, imidazolidine, imidazoline, pyrazolidine, etc. are also included. Preferably, the purine nucleotide or pyrimidine nucleotide may have one or more substituents selected from the following group α, and specifically, the purine-9-1

[0083] α group: hydroxyl group, hydroxyl group protected as a protecting group for nucleic acid synthesis, C1–C5 alkyl group, C1–C5 alkoxy group, mercapto group, mercapto group protected as a protecting group for nucleic acid synthesis, C1–C5 alkylthio group, amino group, amino group protected as a protecting group for nucleic acid synthesis, amino group substituted with a C1–C5 alkyl group, and halogen atom

[0084] A preferred group as a “purine nucleic acid base that may have a substituent” is 6-aminopurine-9-yl (i.e., adeninyl), 6-aminopurine-9-yl, 2,6-diaminopurine-9-yl, 2-amino-6-chloropurine-9-yl, 2-amino-6-chloropurine-9-yl, 2-amino-6-fluoropurine-9-yl, 2-amino-6-fluoropurine-9-yl, 2-amino-6-bromopurine-9-yl, 2-amino-6-bromopurine-9-yl, 2-amino-6-hydroxypurine-9-yl (i.e., guaniyl), wherein one or both of the amino group and the hydroxyl group are protected by a protecting group for nucleic acid synthesis. It is a 2-amino-6-hydroxypurine-9-yl, 6-amino-2-methoxypurine-9-yl, 6-amino-2-chloropurine-9-yl, 6-amino-2-fluoropurine-9-yl, 2,6-dimethoxypurine-9-yl, 2,6-dichloroflorine-2-yl, or 6-mercaptopurine-9-yl group.

[0085] A preferred group as a “pyrimidine nucleic acid base that may have a substituent” is 2-oxo-4-amino-1,2-dihydropyrimidine-1-yl (i.e., cytocinyl), 2-oxo-4-amino-1,2-dihydropyrimidine-1-yl in which one or both of the amino group and the hydroxyl group are protected as protecting groups for nucleic acid synthesis, 2-oxo-4-amino-5-fluoro-1,2-dihydropyrimidine-1-yl, 2-oxo-4-amino-5-fluoro-1,2-dihydropyrimidine-1-yl in which the amino group is protected as a protecting group for nucleic acid synthesis, 4-amino-2-oxo-5-chloro-1,2-dihydropyrimidine-1-yl, 2-oxo-4-methoxy-1,2-dihydropyrimidine-1-yl, 2-oxo-4-mercapto-1,2-dihydropyrimidine-1-yl, 2-oxo-4-hydroxy-1,2-dihydropyrimidine-1-yl (i.e., uracinyl), 2-oxo-4-hydroxy-5-methyl-1,2-dihydropyrimidine-1-yl (i.e., thyminyl), 4-amino-5-methyl-2-oxo-1,2-dihydropyrimidine-1-yl (i.e., 5-methylcytocinyl), or, a 2-oxo-4-amino-5-methyl-1,2-dihydropyrimidine-1-yl group in which the amino group is protected as a protecting group for nucleic acid synthesis.

[0086] Among “purine nucleobases or pyrimidine nucleobases that may have substituents,” more preferably, 6-aminopurine-9-yl (i.e., adeninyl), 6-aminopurine-9-yl in which an amino group is protected as a protecting group for nucleic acid synthesis (e.g., 6-benzoylaminopurine-9-yl, 1-benzyloxymethyl-6-benzoylaminopurine-9-yl), 2-amino-6-hydroxypurine-9-yl (i.e., guaniyl), 2-amino-6-hydroxypurine-9-yl in which one or both of an amino group and a hydroxyl group are protected as protecting groups for nucleic acid synthesis (e.g., 2-isobutyrylamino-6-hydroxypurine-9-yl, 2-isobutyrylamino-6-diphenylcarbamoyloxypurine-9-yl), 2-oxo-4-amino-1,2-dihydropyrimidine-1-yl (i.e., Cytocinyl), 2-oxo-4-amino-1,2-dihydropyrimidine-1-yl (e.g., 2-oxo-4-benzoylamino-1,2-dihydropyrimidine-1-yl) in which an amino group is protected as a protecting group for nucleic acid synthesis, 2-oxo-4-hydroxy-1,2-dihydropyrimidine-1-yl (i.e., uracinyl), 2-oxo-4-hydroxy-5-methyl-1,2-dihydropyrimidine-1-yl (i.e., thyminyl), 4-amino-5-methyl-2-oxo-1,2-dihydropyrimidine-1-yl (i.e., 5-methylcytocinyl), or, 4-amino-5-methyl-2-oxo-1,2-dihydropyrimidine-1-yl (e.g., in which an amino group is protected as a protecting group for nucleic acid synthesis) It is 2-oxo-4-benzoylamino-5-methyl-1,2-dihydropyrimidine-1-yl).

[0087] The protecting group of “protecting amino group in nucleic acid synthesis,” “protecting hydroxyl group in nucleic acid synthesis,” “amino group protected by a protecting group in nucleic acid synthesis,” and “hydroxyl group protected by a protecting group in nucleic acid synthesis” is not particularly limited as long as it is stable during nucleic acid synthesis and capable of protecting an amino group or a hydroxyl group; specifically, it refers to a protecting group that is stable under acidic or neutral conditions and can be cleaved by chemical methods such as hydrolysis, hydrolysis, electrolysis, and photolysis. Examples of such protecting groups include formyl, acetyl, propionyl, butyryl, isobutyryl, pentanoyl, pivaloyl, valeryl, isovaleryl, octanoyl, nonanoyl, decanoyl, 3-methylnonanoyl, 8-methylnonanoyl, 3-ethyloctanoyl, 3,7-dimethyloctanoyl, undettanoyl, dodecanoyl, Alkyl carbonyl groups such as tridecanoyl, tetradecanoyl, pentadecanoyl, hexadecanoyl, 1-methylpentadecanoyl, 14-methylpentadecanoyl, 13,13-dimethyltetradecanoyl, heptadecanoyl, 15-methylhexadecanoyl, octadecanoyl, 1-methylheptadecanoyl, nonadecanoyl, 4-oxopentanoyyl (levrinoyyl), eicosanoyl, and henaicosanoyl; carboxylated alkyl carbonyl groups such as succinoyl, glutaroyl, and adipoyl; halogen lower alkyl carbonyl groups such as chloroacetyl, dichloroacetyl, trichloroacetyl, and trifluoroacetyl; methoxyacetyl, phenoxyacetyl, and 2-(4-tert-butyl)phenoxyacetyl and "Aliphatic acyl groups" such as the same alkoxy lower alkyl carbonyl group, unsaturated alkyl carbonyl groups such as (E)-2-methyl-2-butenoyl;

[0088] "Aromatic acyl groups" such as aryl carbonyl groups like benzoyl, α-naphthoyl, and β-naphthoyl; halogenoaryl carbonyl groups like 2-bromobenzoyl and 4-chlorobenzoyl; lower alkylated aryl carbonyl groups like 2,4,6-trimethylbenzoyl and 4-toluoyl; lower alkoxylated aryl carbonyl groups like 4-anisoyl; carboxylated aryl carbonyl groups like 2-carboxybenzoyl, 3-carboxybenzoyl, and 4-carboxybenzoyl; lower alkoxycarbonylated aryl carbonyl groups like 2-(methoxycarbonyl)benzoyl; nitrated aryl carbonyl groups like 4-nitrobenzoyl and 2-nitrobenzoyl; and arylated aryl carbonyl groups like 4-phenylbenzoyl;

[0089] “Lower alkyl groups” such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, n-hexyl, isohexyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, and 2-ethylbutyl;

[0090] Ethenyl, 1-propenyl, 2-propenyl, 1-methyl-2-propenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 2-methyl-2-propenyl, 2-ethyl-2-propenyl, 1-butenyl, 2-butenyl, 1-methyl-2-butenyl, 1-methyl-1-butenyl, 3-methyl-2-butenyl, 1-ethyl-2-butenyl, 3-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 1-ethyl-3-butenyl, 1-pentenyl, 2-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 4-pentenyl, “Lower alkenyl groups” such as 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, and 5-hexenyl;

[0091] “Halogeno lower alkyl groups” such as 2,2,2-trichloroethyl, 2,2,2-tribromoethyl, 2,2,2-trifluoroethyl, and 2,2,2-trichloro-1,1-dimethylethyl;

[0092] “Aryl groups” such as benzyl, α-naphthylmethyl, β-naphthylmethyl, diphenylmethyl, triphenylmethyl, α-naphthyldiphenylmethyl, 9-anthylmethyl, methyl groups substituted with 1 to 3 aryl groups, lower alkyl, lower alkoxy, halogen, methyl groups substituted with 1 to 3 aryl groups having an aryl ring substituted with a cyano group, lower alkyl, lower alkoxy, halogen, methyl groups substituted with 1 to 3 aryl groups having an aryl ring substituted with a cyano group, lower alkyl, lower alkoxy, halogen, lower alkyl, lower alkoxy

[0093] "An aryl group substituted with a halogen atom, a lower alkoxy group, or a nitro group," such as 4-chlorophenyl, 2-chlorophenyl, 4-methoxyphenyl, 4-nitrophenyl, and 2,4-dinitrophenyl;

[0094] "Silyl groups" such as tri-lower alkylsilyl groups like trimethylsilyl, triethylsilyl, isopropyldimethylsilyl, tert-butyldimethylsilyl, methyldiisopropylsilyl, methyldi-tert-butylsilyl, and triisopropylsilyl, and lower alkylsilyl groups substituted with 1 to 2 aryl groups like diphenylmethylsilyl, tert-butyldiphenylsilyl, diphenylisopropylsilyl, and phenyldiisopropylsilyl;

[0095] “Tetrahydropyranyl or tetrahydrothiopyranyl group” such as tetrahydropyran-2-yl, 3-bromotetrahydropyran-2-yl, 4-methoxytetrahydropyran-4-yl, tetrahydrothiopyran-4-yl, and 4-methoxytetrahydrothiopyran-4-yl;

[0096] "Tetrahydrofuranyl or tetrahydrothiofuranyl group" such as tetrahydrofuran-2-yl and tetrahydrothiofuran-2-yl;

[0097] “Lower alkoxyalkyl groups” such as lower alkoxymethyl groups like methoxymethyl, 1,1-dimethyl-1-methoxymethyl, ethoxymethyl, propoxymethyl, isopropoxymethyl, butoxymethyl, tert-butoxymethyl, and lower alkoxyethyl groups like 1-ethoxyethyl and 1-(isopropoxy)ethyl;

[0098] “Lower alkoxylated lower alkoxymethyl group” such as 2-methoxyethoxymethyl;

[0099] “Halogeno lower alkoxymethyl groups” such as 2,2,2-trichloroethoxymethyl and bis(2-chloroethoxy)methyl;

[0100] “An aryloxymethyl group that may have an aryl ring substituted with 1 to 2 lower alkoxy or nitro groups,” such as benzyloxymethyl, 4-methoxybenzyloxymethyl, and 2-naphthylmethoxymethyl;

[0101] Lower alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, isobutoxycarbonyl; lower alkoxycarbonyl groups substituted with a halogen or tri-lower alkylsilyl group such as 2,2,2-trichloroethoxycarbonyl, 2-trimethylsilylethoxycarbonyl; alkenyloxycarbonyl groups such as vinyloxycarbonyl, allyloxycarbonyl; aralkyloxycarbonyl groups in which an aryl ring may be substituted with one or two lower alkoxy or nitro groups such as benzyloxycarbonyl, 4-methoxybenzyloxycarbonyl, 3,4-dimethoxybenzyloxycarbonyl, 2-nitrobenzyloxycarbonyl, 4-nitrobenzyloxycarbonyl; and “oxycarbonyl groups” such as 9-fluorenylmethyloxycarbonyl;

[0102] There is a “carbamoyl group in which the nitrogen atom may be substituted with an alkyl group, aryl group, alkenyl group, lower alkoxy group, or aralkyl group,” such as dimethylcarbamoyl, diphenylcarbamoyl, methylphenylcarbamoyl, 1-pyrrolidinylcarbamoyl, and morpholinocarbamoyl, and for example, in the “protecting group of a hydroxyl group in nucleic acid synthesis,” preferably, it is an “aliphatic acyl group,” an “aromatic acyl group,” a “methyl group substituted with 1 to 3 aryl groups,” a “methyl group substituted with 1 to 3 aryl groups in which an aryl ring is substituted with a lower alkyl, lower alkoxy, halogen, or cyano group,” or a “silyl group,” and more preferably, an acetyl group, a benzoyl group, a benzyl group, a p-methoxybenzoyl group, a dimethoxytrityl group, a monomethoxytrityl group, or a tert-butyldiphenylsilyl group. The protecting group of the “hydroxyl group protected as a protecting group in nucleic acid synthesis” is preferably an “aliphatic acyl group,” an “aromatic acyl group,” a “methyl group substituted with 1 to 3 aryl groups,” an “aryl group substituted with a halogen atom, a lower alkoxy group or a nitro group,” a “lower alkyl group,” or a “lower alkenyl group,” and more preferably a benzoyl group, a benzyl group, a 2-chlorophenyl group, a 4-chlorophenyl group, or a 2-propenyl group.

[0103] As for the protecting group of the “mercapto group protected as a protecting group for nucleic acid synthesis,” it is not particularly limited as long as it is stable during nucleic acid synthesis and can protect the mercapto group, but specifically, it refers to a protecting group that is stable under acidic or neutral conditions and can be cleaved by chemical methods such as hydrolysis, hydrolysis, electrolysis, and photolysis. For example, in addition to the protecting group of the above hydroxyl group, examples include “groups that form disulfides” such as alkylthio groups like methylthio, ethylthio, and tert-butylthio, and arylthio groups like benzylthio. Preferably, it is an “aliphatic acyl group” or an “aromatic acyl group,” and more preferably, a benzoyl group.

[0104] The “protecting group” in “a protected phosphate group as a protecting group in nucleic acid synthesis” is not particularly limited as long as it is stable during nucleic acid synthesis and capable of protecting a phosphate group, but specifically refers to a protecting group that is stable under acidic or neutral conditions and can be cleaved by chemical methods such as hydrolysis, hydrolysis, electrolysis, and photolysis. Examples of such protecting groups include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, n-hexyl, isohexyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, “Lower alkyl groups” such as 2,3-dimethylbutyl and 2-ethylbutyl;

[0105] "Cyaninated lower alkyl groups" such as 2-cyanoethyl and 2-cyano-1,1-dimethylethyl;

[0106] “ethyl groups substituted with silyl groups” such as 2-methyldiphenylsilylethyl, 2-trimethylsilylethyl, and 2-triphenylsilylethyl;

[0107] “Halide lower alkyl groups” such as 2,2,2-trichloroethyl, 2,2,2-tribromoethyl, 2,2,2-trifluoroethyl, and 2,2,2-trichloro-1,1-dimethylethyl;

[0108] Ethenyl, 1-propenyl, 2-propenyl, 1-methyl-2-propenyl, 1-methyl-1-propenyl, 2-methyl-2-propenyl, 2-ethyl-2-propenyl, 1-butenyl, 2-butenyl, 1-methyl-2-butenyl, 1-methyl-1-butenyl, 3-methyl-2-butenyl, 1-ethyl-2-butenyl, 3-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 1-ethyl-3-butenyl, 1-pentenyl, 2-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 4-pentenyl, 1-methyl-4-pentenyl, “Lower alkenyl groups” such as 2-methyl-4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, and 5-hexenyl;

[0109] “Cycloalkyl groups” such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, norbornyl, and adamantyl;

[0110] "Cyanogenic lower alkenyl groups" such as 2-cyanobutenyl;

[0111] Benzyl, α-Naphthylmethyl, β-Naphthylmethyl, Indenylmethyl, Phenanthrenylmethyl, Anthracenylmethyl, Diphenylmethyl, Triphenylmethyl, 1-Phenethyl, 2-Phenethyl, 1-Naphthylethyl, 2-Naphthylethyl, 1-Phenylpropyl, 2-Phenylpropyl, 3-Phenylpropyl, 1-Naphthylpropyl, 2-Naphthylpropyl, 3-Naphthylpropyl, 1-Phenylbutyl, 2-Phenylbutyl, 3-Phenylbutyl, 4-Phenylbutyl, 1-Naphthylbutyl, 2-Naphthylbutyl, 3-Naphthylbutyl, 4-Naphthylbutyl, 1-Phenylpentyl, 2-Phenylpentyl, 3-Phenylpentyl, 4-Phenylpentyl, 5-Phenylpentyl, 1-Naphthylpentyl, 2-Naphthylpentyl, 3-Naphthylpentyl, "Aryl groups" such as 4-naphthylpentyl, 5-naphthylpentyl, 1-phenylhexyl, 2-phenylhexyl, 3-phenylhexyl, 4-phenylhexyl, 5-phenylhexyl, 6-phenylhexyl, 1-naphthylpentyl, 2-naphthylpentyl, 3-naphthylpentyl, 4-naphthylpentyl, 5-naphthylpentyl, and 6-naphthylpentyl;

[0112] “A nitro group, an aryl ring substituted with a halogen atom” such as 4-chlorobenzyl, 2-(4-nitrophenyl)ethyl, o-nitrobenzyl, 4-nitrobenzyl, 2,4-dinitrobenzyl, and 4-chloro-2-nitrobenzyl;

[0113] "Aryl groups" such as phenyl, indenyl, naphthyl, phenanthrenyl, and anthracenyl;

[0114] Examples include “a lower alkyl group, a halogen atom, and an aryl group substituted with a nitro group” such as 2-methylphenyl, 2,6-dimethylphenyl, 2-chlorophenyl, 4-chlorophenyl, 2,4-dichlorophenyl, 2,5-dichlorophenyl, 2-bromophenyl, 4-nitrophenyl, and 4-chloro-2-nitrophenyl, preferably a “lower alkyl group,” a “lower alkyl group substituted with a cyano group,” an “aryl alkyl group,” an “aryl alkyl group in which an aryl ring is substituted with a nitro group or a halogen atom,” or an “aryl group substituted with a lower alkyl group, a halogen atom, or a nitro group,” and more preferably a 2-cyanoethyl group, a 2,2,2-trichloroethyl group, a benzyl group, a 2-chlorophenyl group, or a 4-chlorophenyl group.

[0115] "Alkyl group" typically represents a straight-chain or branched-chain alkyl group having 1 to 20 carbon atoms, and in addition to straight-chain or branched-chain alkyl groups having 1 to 6 carbon atoms such as, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, n-hexyl, isohexyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, and 2-ethylbutyl (in this specification, these are also referred to as lower alkyl groups), heptyl, octyl, It includes straight-chain or branched-chain alkyl groups having 7 to 20 carbon atoms, such as nonyl and decyl. Additionally, a portion thereof may form a ring.

[0116] "Alkoxy group" typically refers to an alkoxy group having the above-mentioned alkyl group, and includes, for example, methyloxy(methoxy), ethyloxy(ethoxy), n-propyloxy(n-propoxy), isopropoxy, n-butyloxy(n-butoxy), isobutoxy, sec-butoxy, tert-butoxy, n-pentyloxy(n-pentoxy), etc.

[0117] "Cyanoalkoxy group" typically refers to a group in which any number of cyano groups are substituted on the alkoxy group, such as cyanomethoxy, 2-cyanoethoxy, 3-cyanopropoxy, 4-cyanobutoxy, 3-cyano-2-methylpropoxy, 1-cyanomethyl-1,1-dimethylmethoxy, 5-cyanopenthyloxy, and 6-cyanohexyloxy.

[0118] "Alkylthio group" typically refers to an alkylthio group having the above alkyl group, and includes, for example, methylthio, ethylthio, propylthio, isopropylthio, butylthio, isobutylthio, sec-butylthio, tert-butylthio, n-pentylthio, etc.

[0119] "Alkylamino group" typically refers to an alkylamino group having one or two of the above alkyl groups, and includes, for example, methylamino, ethylamino, propylamino, isopropylamino, butylamino, isobutylamino, sec-butylamino, tert-butylamino, dimethylamino, diethylamino, dipropylamino, diisopropylamino, dibutylamino, diisobutylamino, di(sec-butyl)amino, di(tert-butyl)amino, pentylamino, etc.

[0120] The "alkenyl group" typically represents a straight-chain or branched-chain alkenyl group having 2 to 20 carbon atoms, and is, for example, ethenyl, 1-propenyl, 2-propenyl, 1-methyl-2-propenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 2-methyl-2-propenyl, 2-ethyl-2-propenyl, 1-butenyl, 2-butenyl, 1-methyl-2-butenyl, 1-methyl-1-butenyl, 3-methyl-2-butenyl, 1-ethyl-2-butenyl, 3-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 1-ethyl-3-butenyl, 1-pentenyl, 2-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-pentenyl, In addition to straight-chain or branched-chain alkenyl groups having 2 to 6 carbon atoms, such as 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 4-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, and 5-hexenyl (in this specification, these are also referred to as lower alkenyl groups), heptenyl, geranyl, farnesyl, etc., are included. Furthermore, a portion thereof may form a ring.

[0121] "Aryl group" usually refers to a monovalent substituent having 6 to 14 carbon atoms from which one hydrogen atom has been removed from an aromatic hydrocarbon group, and examples include phenyl, indenyl, naphthyl, phenanthrenyl, anthracenyl, etc. In addition, the aryl ring may be substituted by one or more groups such as a halogen atom, a lower alkyl group, a hydroxyl group, an alkoxy group, an aryloxy group, an amino group, a nitro group, a trifluoromethyl group, a phenyl group, etc. Examples of such substituted aryl groups include 2-methylphenyl, 2,6-dimethylphenyl, 2-chlorophenyl, 4-chlorophenyl, 2,4-dichlorophenyl, 2,5-dichlorophenyl, 2-bromophenyl, 4-methoxyphenyl, 4-chloro-2-nitrophenyl, 4-nitrophenyl, 2,4-dinitrophenyl, biphenyl, etc. In addition, the aryl group may include heteroatoms, for example, a heteroaryl in which at least one carbon atom constituting the ring structure of the aryl group is substituted with a heteroatom (e.g., a nitrogen atom, an oxygen atom, a sulfur atom, etc.). Examples of heteroaryls include pyridyl, pyrrolyl, quinolyl, indolyl, imidazolyl, furyl, thienyl, etc.

[0122] "Aralkyl group" generally refers to an alkyl group having 1 to 6 carbon atoms substituted with an aryl group, and includes, for example, "methyl groups substituted with 1 to 3 aryl groups" such as benzyl, α-naphthylmethyl, β-naphthylmethyl, indenylmethyl, phenanthrenylmethyl, anthracenylmethyl, diphenylmethyl, triphenylmethyl, α-naphthyldiphenylmethyl, and 9-anthylmethyl, or "methyl groups in which an aryl ring is substituted with a lower alkyl, lower alkoxy, halogen, or cyano group" such as 4-methylbenzyl, 2,4,6-trimethylbenzyl, 3,4,5-trimethylbenzyl, 4-methoxybenzyl, 4-methoxyphenyldiphenylmethyl, 4,4'-dimethoxytriphenylmethyl, 2-nitrobenzyl, 4-nitrobenzyl, 4-chlorobenzyl, 4-bromobenzyl, and 4-cyanobenzyl. In addition to "methyl groups substituted with 1 to 3 aryl groups," 1-phenethyl, 2-phenethyl, 1-naphthylethyl, 2-naphthylethyl, 1-phenylpropyl, 2-phenylpropyl, 3-phenylpropyl, 1-naphthylpropyl, 2-naphthylpropyl, 3-naphthylpropyl, 1-phenylbutyl, 2-phenylbutyl, 3-phenylbutyl, 4-phenylbutyl, 1-naphthylbutyl, 2-naphthylbutyl, 3-naphthylbutyl, 4-naphthylbutyl, 1-phenylpentyl, 2-phenylpentyl, 3-phenylpentyl, 4-phenylpentyl, 5-phenylpentyl, 1-naphthylpentyl, 2-naphthylpentyl, 3-naphthylpentyl, 4-naphthylpentyl, 5-naphthylpentyl, 1-naphthylpentyl, 2-naphthylpentyl, 4-naphthylpentyl, 5-naphthylpentyl, 1-phenylhexyl, 2-phenylhexyl, Includes “alkyl groups having 2 to 6 carbon atoms substituted with aryl groups” such as 3-phenylhexyl, 4-phenylhexyl, 5-phenylhexyl, 6-phenylhexyl, 1-naphthylpentyl, 2-naphthylpentyl, 3-naphthylpentyl, 4-naphthylpentyl, 5-naphthylpentyl, and 6-naphthylpentyl.

[0123] As for the "acyl group," examples include formyl, acetyl, propionyl, butyryl, isobutyryl, pentanoyl, pivaloyl, valeryl, isovaleryl, octanoyl, nonanoyl, decanoyl, 3-methylnonanoyl, 8-methylnonanoyl, 3-ethyloctanoyl, 3,7-dimethyloctanoyl, undecanoyl, dodecanoyl, tridecanoyl, tetradecanoyl, pentadecanoyl, hexadecanoyl, 1-methylpentadecanoyl, 14-methylpentadecanoyl, 13,13-dimethyltetradecanoyl, heptadecanoyl, 15-methylhexadecanoyl, octadecanoyl, 1-methylheptadecanoyl, nonadecanoyl, eicosanoyl, and henaicosanoyl. "Aliphatic acyl groups" such as alkyl carbonyl groups, carboxylated alkyl carbonyl groups such as succinoyl, glutaroyl, and adipoyl, halogen lower alkyl carbonyl groups such as chloroacetyl, dichloroacetyl, trichloroacetyl, and trifluoroacetyl, lower alkoxy lower alkyl carbonyl groups such as methoxyacetyl, and unsaturated alkyl carbonyl groups such as (E)-2-methyl-2-butenoyl, and aryl carbonyl groups such as benzoyl, α-naphthoyl, and β-naphthoyl, halogen aryl carbonyl groups such as 2-bromobenzoyl and 4-chlorobenzoyl, lower alkylated aryl carbonyl groups such as 2,4,6-trimethylbenzoyl and 4-toluoyl, and lower alkoxylated aryl carbonyl groups such as 4-anisoyl, There are “aromatic acyl groups” such as carboxylated aryl carbonyl groups like 2-carboxybenzoyl, 3-carboxybenzoyl, and 4-carboxybenzoyl; nitrated aryl carbonyl groups like 4-nitrobenzoyl and 2-nitrobenzoyl; lower alkoxycarbonylated aryl carbonyl groups like 2-(methoxycarbonyl)benzoyl; and arylated aryl carbonyl groups like 4-phenylbenzoyl.

[0124] Examples of “silyl groups” include “tri-lower alkylsilyl groups” such as trimethylsilyl, triethylsilyl, isopropyldimethylsilyl, tert-butyldimethylsilyl, methyldiisopropylsilyl, methyldi-tert-butylsilyl, and triisopropylsilyl, and “lower alkylsilyl groups substituted with 1 to 2 aryl groups” such as diphenylmethylsilyl, butyldiphenylbutylsilyl, diphenylisopropylsilyl, and phenyldiisopropylsilyl.

[0125] Examples of "halogen atoms" include fluorine atoms, chlorine atoms, bromine atoms, or iodine atoms.

[0126] Next, the present invention will be described in detail.

[0127] The method for manufacturing a compound represented by Formula (III) of the present invention is a method for manufacturing a compound represented by Formula (I) as a raw material, and includes at least a process using the compound represented by Formula (I).

[0128]

[0129] (during the meal,

[0130] X represents a nucleotide portion that may have one or more arbitrary substituents selected from group α;

[0131] R 1 and R 2 Each independently comprises a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0132] R 5 ...represents a hydrogen atom; a halogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with an aryl group having 3 to 12 carbon atoms that may contain a heteroatom and may also form a branch or ring; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may contain a heteroatom; or a silyl group.

[0133] As X in formula (I), the above-mentioned nucleobase portion can be cited as an example. Among these, from the perspective of introduction into a nucleic acid drug, a purine nucleobase or a pyrimidine nucleobase that may have a substituent is preferred, and for example, the following structural formula:

[0134]

[0135] 2-oxo-4-hydroxy-5-methyl-1,2-dihydropyrimidine-1-yl group (thyminyl group), 2-oxo-4-amino-1,2-dihydropyrimidine-1-yl group (cytocinyl group), 6-aminopurine-9-yl group (adeninyl group), 2-amino-6-hydroxypurine-9-yl group (guanil group), 4-amino-5-methyl-2-oxo-1,2-dihydropyrimidine-1-yl group, and 2-oxo-4-hydroxy-1,2-dihydropyrimidine-1-yl group (uracilyl group) and one or more of diamino groups and carbonyl groups protected by a protecting group, and tautomers thereof are preferred.

[0136] R in Equation (I) 1 ~R 5 Each can be appropriately set independently by referring to the aforementioned substituents. And, -P(R 3 )R 4Examples of groups represented by include, preferably, the group represented by the formula P(OC2H4CN)(N(iPr)2) and the group represented by the formula P(OCH3)(N(iPr)2). Here, iPr represents an isopropyl group.

[0137] As a manufacturing method using a compound represented by formula (I) as a raw material, for example, a method using a compound represented by formula (II) obtained by intramolecularly cyclizing a compound represented by formula (I) can be cited. Accordingly, as one aspect of the present invention, a method comprising at least a process of intramolecularly cyclizing a compound represented by formula (I) can be cited as an example. Subsequently, the above process may be described as process A.

[0138] As a method for intramolecular cyclization, methods known in the art can be used, for example, by using the addition reaction of an alcohol to an alkyne. In the addition reaction, it is generally preferable to add a base to the substrate and carry out the reaction by cooling or heating in a solvent or solvent-free environment as needed.

[0139] As bases, alkoxides such as sodium methoxide, sodium ethoxide, sodium tert-butoxide, lithium methoxide, lithium ethoxide, lithium tert-butoxide, potassium methoxide, potassium ethoxide, potassium tert-butoxide; carbonates such as sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate; organometallic reagents such as methyl lithium, ethyl lithium, n-butyl lithium, and methyl magnesium chloride; metal hydrides such as sodium hydride; metal amides such as lithium diisopropylamide, lithium hexamethyldisilazide, sodium hexamethyldisilazide, and lithium dicyclohexylamide; Examples of organic bases include triethylamine, diisopropylethylamine, tributylamine, tert-butylamine, N,N-dimethylaniline, N,N-diethylaniline, pyridine, 4-dimethylaminopyridine, pyrrolidine, piperidine, colidine, rutidine, morpholine, piperazine, diazabicycloundecene, diazabicyclononene, and 1,4-diazabicyclo[2.2.2]octane. These bases may be used alone or in combination, and may be selected based on the type of substrate, reactivity, or selectivity.

[0140] The amount of substrate, base, etc., used in the reaction, the reaction temperature, the reaction time, etc., can be appropriately set according to known technology. For example, the reaction temperature is -80 to 200 ℃, the reaction time is 1 to 24 hours, and the amount of base used is 1.0 equivalent to 30 equivalents. In addition, purification after the reaction is not particularly limited.

[0141] The compound represented by formula (I) is the above R 1 ~R 5 As long as it has X, commercially available products or those prepared according to known methods may be used. For example, there are compounds having a uracil skeleton or a cytosine skeleton, where X may have a substituent (preferably a hydroxyl group, an amino group, a hydroxyl group protected by a protecting group, and amino group), and their tautomers. Specific structures are shown below.

[0142]

[0143] Likewise, examples are provided of compounds represented by formula (I) having a purine skeleton where X may have a substituent (preferably a hydroxyl group, an amino group, a hydroxyl group protected by a protecting group, and an amino group) and their tautomers. Specific structures are shown below.

[0144]

[0145] And, in the present invention, as a compound represented by formula (I), X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 and R 2 Benzyl group, R 5 A compound in which is a hydrogen atom, and X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 , R 2 and R 5 You can also use compounds in which hydrogen atoms are present.

[0146] In addition, the compound represented by formula (I) can be prepared by deprotecting the compound represented by formula (IV) below. Accordingly, as an example of one aspect of the present invention, a manufacturing method may be given that further comprises a process of deprotecting the compound represented by formula (IV) below to produce the compound represented by formula (I).

[0147]

[0148] (during the meal,

[0149] X represents a nucleotide portion that may have one or more arbitrary substituents selected from group α;

[0150] R 1 and R 2Each independently comprises a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4 Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0151] R 5 ...represents a hydrogen atom; a halogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with an aryl group having 3 to 12 carbon atoms that may contain a heteroatom and may also form a branch or ring; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may contain a heteroatom; or a silyl group;

[0152] R 6 represents the protecting group of the hydroxyl group in nucleic acid synthesis.

[0153] Among these, as a preferred embodiment of the present invention, the compound represented by formula (I) is a group R 6 An example of a sun can be prepared by deprotecting a compound represented by formula (IV), which indicates a group that can be removed.

[0154] R in Equation (IV) 1 ~R 6 and X can each be appropriately set by referring to the substituents mentioned above, independently, and can be selected according to the structure of the compound represented by the desired formula (I).

[0155] As a method for deprotection, it can be appropriately selected according to the type of protector and methods known in the above technical field. For example, R 6 When the group is an acetyl group, it is preferable to dissolve it in an organic solvent, add a base, and carry out the reaction by cooling or heating as necessary. For example, the reaction temperature is -80 to 200 ℃, the reaction time is 0.1 to 24 hours, and the amount of base used is 1.0 equivalent to 30 equivalents.

[0156] The compound represented by formula (IV) is the above R 1 ~R 6 If it has and X, it may be a commercially available product or one prepared according to known methods. For example, R 6 There are compounds in which α is an acetyl group, or in which α is a group having a uracil skeleton or a cytosine skeleton, wherein α may have a substituent (preferably a hydroxyl group, an amino group, a hydroxyl group protected by a protecting group, and an amino group), and tautomers thereof. Specific structures are shown below.

[0157]

[0158] Likewise, examples of compounds represented by formula (IV) include compounds having a purine skeleton in which X may have a substituent (preferably a hydroxyl group, an amino group, a hydroxyl group protected by a protecting group, and an amino group) and their tautomers. Specific structures are shown below.

[0159]

[0160] And, in the present invention, as a compound represented by formula (IV), X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 and R 2 ga is a benzyl group, and R 6 A compound in which ga is an acetyl group, and X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 , R 2 and R 6 Compounds containing an acetyl group may also be used.

[0161] In addition, the compound represented by formula (I) can be prepared, for example, using a compound represented by the following formula (V) as a raw material. Accordingly, as an example of one aspect of the present invention, a manufacturing method comprising a process of preparing a compound represented by formula (I) using a compound represented by the following formula (V) as a raw material can be given.

[0162]

[0163] (during the meal,

[0164] R 1 and R 2Each independently, a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4 Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0165] Here, the α group comprises a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an alkylthio group having 1 to 5 carbon atoms, an amino group, an amino group protected by a protecting group for nucleic acid synthesis, an amino group substituted with an alkyl group having 1 to 5 carbon atoms, and a halogen atom.

[0166] R 6 and R 7Each is independently a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, or a phosphate group protected by a protecting group in nucleic acid synthesis, or

[0167] R 6 and R 7 ...becomes together, -C(R 8 )(R 9 )-[In the formula, R 8 and R 9 [represents, respectively, a hydrogen atom, an alkyl group having 1 to 7 carbon atoms that may be substituted with a 3 to 12 carbon atom aryl group that may contain a hydrogen atom or a heteroatom and may also form a branch or ring, or an aryl group having a 3 to 12 carbon atom aryl portion that may contain a heteroatom]

[0168] R in Equation (V) 1 ~R 4 and R 6 ~R 7 Each can be independently set appropriately by referring to the substituents mentioned above, and can be selected according to the structure of the compound represented by the desired formula (I).

[0169] As a method for preparing the compound of formula (I) from the compound of formula (V), it may be done by referring to methods known in the art, but for the sake of simplifying the manufacturing process, it may be done as follows.

[0170] Specifically, for example, first, a compound of formula (V) is reacted in the presence of a reactant to prepare a 4-formyl compound represented by formula (VI). The reaction temperature is preferably -80 to 200 ℃, and the reaction time is preferably 0.1 to 24 hours.

[0171]

[0172] (during the meal,

[0173] R 1 and R 2 Each independently, a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0174] Here, the α group comprises a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an alkylthio group having 1 to 5 carbon atoms, an amino group, an amino group protected by a protecting group for nucleic acid synthesis, an amino group substituted with an alkyl group having 1 to 5 carbon atoms, and a halogen atom.

[0175] R 6 and R 7 Each is independently a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, or a phosphate group protected by a protecting group in nucleic acid synthesis, or

[0176] R 6 and R 7 ...becomes together, -C(R 8 )(R 9 )-[In the formula, R 8 and R 9[represents, respectively, a hydrogen atom, an alkyl group having 1 to 7 carbon atoms that may be substituted with a 3 to 12 carbon atom aryl group that may contain a hydrogen atom or a heteroatom and may also form a branch or ring, or an aryl group having a 3 to 12 carbon atom aryl portion that may contain a heteroatom]

[0177] As a reactant, a reactant used in known oxidation reactions may be used. For example, known oxidizing agents may be used, such as Des-Martine reagent, 2,2,6,6-tetramethylpiperidine-1-oxyl radical / sodium hypochlorite, oxalyl chloride / dimethyl sulfoxide, acetic anhydride / dimethyl sulfoxide, trifluoroacetic anhydride / dimethyl sulfoxide, dicyclohexylcarbodiimide / dimethyl sulfoxide, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide / dimethyl sulfoxide, sulfur trioxide-pyridine complex / dimethyl sulfoxide, etc. Among these, sulfur trioxide-pyridine complex / dimethyl sulfoxide, which has mild reaction conditions, is preferred. The amount of reactant used is preferably 1.0 to 20 equivalents.

[0178] R in Equation (VI) 1 ~R 4 and R 6 ~R 7 Each can be independently set appropriately by referring to the substituents mentioned above, and can be selected according to the structure of the compound represented by the desired formula (I).

[0179] Next, the obtained 4-formyl compound is reacted according to a known method to prepare a 4-dibromoetenyl compound.

[0180] Next, R to the 4-dibromoetenyl compound 5 By introducing R 5 Prepare a 4-ethynyl compound having, or prepare a 4-ethynyl compound from a 4-dibromoethenyl compound, and also R 5 By introducing R 5 Prepare a 4-ethynyl compound having

[0181] After that, concentrated sulfuric acid is added to the acetic acid-acetic anhydride solution of the obtained 4-ethynyl compound to synthesize a compound represented by the following formula (VII), and the compound of formula (I) can be prepared by introducing a nucleic acid base portion at position 1 of the compound. Preferably, the reaction temperature for preparing the compound of formula (VII) is 0 to 40 ℃, the reaction time is 0.1 to 24 hours, and the amount of concentrated sulfuric acid used is 0.01 to 1.0 equivalents. By using the above reaction conditions, it is possible to perform a two-step reaction in one step, and the efficiency of the synthesis can be improved.

[0182]

[0183] (during the meal,

[0184] R 1 and R 2 Each independently, a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may contain a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0185] Here, the α group comprises a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an alkylthio group having 1 to 5 carbon atoms, an amino group, an amino group protected by a protecting group for nucleic acid synthesis, an amino group substituted with an alkyl group having 1 to 5 carbon atoms, and a halogen atom.

[0186] R 5 ...represents a hydrogen atom; a halogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with an aryl group having 3 to 12 carbon atoms that may contain a heteroatom and may also form a branch or ring; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may contain a heteroatom; or a silyl group;

[0187] R 6 and R 7Each represents, independently, a protecting group of a hydroxyl group in nucleic acid synthesis; an alkyl group having 1 to 7 carbon atoms that may form a branch or ring; an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring; an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom; an acyl group having one or more substituents selected from group α; a silyl group having one or more substituents selected from group α; a phosphate group having one or more substituents selected from group α; or a phosphate group protected by a protecting group in nucleic acid synthesis).

[0188] R in Equation (VII) 1 ~R 7 Each can be independently set appropriately by referring to the substituents mentioned above, and can be selected according to the structure of the compound represented by the desired formula (I).

[0189] The compound represented by formula (V) is the above R 1 ~R 4 and R 6 ~R 7 If it has [the following], it may be a commercially available product or one prepared according to a known method.

[0190] The purification of the compound represented by the obtained formula (I) may be appropriately carried out according to known techniques.

[0191] In this way, a compound represented by the following formula (II) can be prepared from a compound represented by formula (I) by process A.

[0192]

[0193] (during the meal,

[0194] X represents a nucleotide portion that may have one or more arbitrary substituents selected from group α;

[0195] R 1 and R 2 Each independently comprises a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4 Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0196] R 5 ...represents a hydrogen atom; a halogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with an aryl group having 3 to 12 carbon atoms that may contain a heteroatom and may also form a branch or ring; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may contain a heteroatom; or a silyl group).

[0197] And, the substituents in formula (II) are appropriately set according to the compound represented by formula (I) used.

[0198] Next, a method for preparing a compound represented by the following formula (III) from a compound represented by formula (II) will be described. Specifically, the compound represented by formula (II) can be prepared by cyclopropaneizing it. Accordingly, as one aspect of the present invention, a method including a process of cyclopropaneizing a compound represented by formula (II) can be given as an example. Subsequently, the above process may be described as process B.

[0199]

[0200] (during the meal,

[0201] X represents a nucleotide portion that may have one or more arbitrary substituents selected from group α;

[0202] R 1 and R 2 Each independently comprises a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R3 and R 4 Each represents, independently, a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, an alkoxy group having 1 to 5 carbon atoms, an alkylthio group having 1 to 5 carbon atoms, a cyanoalkoxy group having 1 to 6 carbon atoms, or an amino group substituted with an alkyl group having 1 to 6 carbon atoms;

[0203] R5 and R5' represent a hydrogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with a 3 to 12 carbon atom aryl group that may contain a heteroatom and may also form a branch or ring; or an aralkyl group having a 3 to 12 carbon atom aryl portion that may contain a heteroatom).

[0204] As a method for cyclopropanation, for example, the Simmons-Smith reaction can be used. The above reaction can be carried out in the presence of a zinc carbenoid, and there are also methods using diethyl zinc instead of zinc or using a CH2N2-ZnI2-based agent. For example, the amount of zinc carbenoid to be reacted is preferably 1.0 to 20 equivalents.

[0205] Since the cyclopropanation reaction of Process B varies depending on the type of zinc carbenoid, it may be carried out in the presence of an organic acid. The presence of an organic acid enables the suppression of precipitation and side reactions. As long as the organic acid is known, there are no restrictions, and formic acid, acetic acid, dichloroacetic acid, trichloroacetic acid, trifluoroacetic acid, diphenylphosphate, thosic acid, phenol, etc., may be preferably used. The amount of organic acid used is, for example, 0.5 to 2.0 equivalents relative to the zinc carbenoid used.

[0206] The reaction in the presence of the above-mentioned organic acid can be applied without particular limitation to the compound represented by formula (II), but compounds in which X in formula (II) has a purine skeleton and their tautomers are preferred.

[0207] In addition, the compound represented by Formula (II) provided for the reaction may be a commercially available product or one prepared according to a known method. Alternatively, one prepared according to Process A described above may be used.

[0208] Compounds represented by formula (II) include, for example, compounds having a uracil skeleton or a cytosine skeleton where X may have a substituent (preferably a hydroxyl group, an amino group, a hydroxyl group protected by a protecting group, and an amino group), and tautomers thereof. Specific structures are shown below.

[0209]

[0210] Likewise, examples of compounds represented by formula (II) include compounds having a purine skeleton in which X has a substituent (preferably a hydroxyl group, an amino group, a hydroxyl group protected by a protecting group, and an amino group) and compounds that are tautomers thereof. Specific structures are shown below.

[0211]

[0212] And, in the present invention, as a compound represented by formula (II), X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 This naphthyl group, R 2 Benzyl group, R 5 A compound in which is a hydrogen atom, and X is a 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl group, and R 1 This naphthyl group, R 2 and R 5 You can also use compounds in which hydrogen atoms are present.

[0213] In addition, from the perspective of improving yield, the compound represented by formula (II) provided for cyclopropanization may be, for example, a compound in which some or all of the active reactive groups are protected by known protecting groups, where an active reactive group is present on group X. For example, if X is a compound having a purine backbone into which a protecting group has been introduced, it is possible to suppress side reactions with X as a reaction site, thereby improving yield.

[0214] The purification of the compound obtained in process B can be appropriately carried out according to known techniques. For example, a process of post-treating the reaction solution with ammonia may be included to facilitate post-treatment of the reaction. By treating with ammonia, the removal of reagent residues becomes easier and can be used advantageously.

[0215] The above post-treatment method can be applied to compounds represented by various formulas (III), but compounds in which X in formula (III) has a pyrimidine backbone are preferred. In this case, the boundary between the organic layer and the water layer becomes clear, making it possible to distribute efficiently.

[0216] In this way, a compound represented by formula (III) can be prepared from a compound represented by formula (II).

[0217] As one aspect of the present invention, if a compound represented by formula (II) prepared according to process A is used, an example of a method for preparing a compound represented by formula (III) of the present invention may be a method comprising at least process A and process B. Additionally, a method comprising a process of preparing a compound represented by formula (I) in process A by the above method is also included. The compound represented by formula (III) may be a compound having a group protected as a protecting group for nucleic acid synthesis (hydroxyl group, mercapto group, amino group, etc.) as X, or a compound having some or all of the protected groups for nucleic acid synthesis as unprotected groups. As a method for unprotecting the protected groups for nucleic acid synthesis (hydroxyl group, mercapto group, amino group, etc.), unprotection may be performed by a known method [e.g., treatment with a weak acid (e.g., carboxylic acid, silica gel, etc.)].

[0218] In addition, when preparing compounds represented by various formulas (III), the present invention allows for efficient preparation by, for example, preparing a compound represented by formula (VII) in common and then introducing a desired nucleic acid base portion therein.

[0219] The compound represented by formula (III) obtained by the present invention can be amidite-ized according to a known method. The obtained amidite derivative is expected to be useful as a raw material for the synthesis of nucleic acid drugs (antisense nucleic acid drugs) that treat diseases by inhibiting the activity of specific genes.

[0220] [Example]

[0221] The present invention will be described in detail below by way of examples, but the present invention is not limited thereto. Also, in the following examples, room temperature means 15 to 35 ℃.

[0222] Example 1: Synthesis of a common intermediate compound

[0223]

[0224] (1) Synthesis of Compound 2

[0225]

[0226] Dimethyl sulfoxide (32 mL, 0.45 mol, 9.0 eq) and triethylamine (27.7 mL, 0.200 mol, 4.0 eq) were added to an anhydrous dichloromethane solution (167 mL) of compound 1 (20 g, 50 mmol), and after cooling to an indoor temperature of 7 °C, a small amount of sulfur trioxide-pyridine complex (15.9 g, 0.100 mol, 2.0 eq) was added and stirred at room temperature for 21.5 hours. Tap water (300 mL) was added to this reaction solution, and extraction and separation were performed using a mixed solvent of ethyl acetate (200 mL) and hexane (100 mL) to obtain organic layer I and aqueous layer I. Organic layer I was washed with a mixture of tap water (200 mL) and a saturated aqueous solution of ammonia chloride (100 mL) to obtain organic layer II and aqueous layer II. Organic layer II was further washed with a mixture of tap water (100 mL) and a saturated aqueous solution of ammonia chloride (100 mL) to obtain organic layer III and aqueous layer III. Aqueous layers II and III were combined, extracted with ethyl acetate (100 mL), washed with tap water (100 mL), and obtained organic layer IV. Organic layers III and IV were combined, washed with a saturated saline solution (100 mL), dried with anhydrous sodium sulfate, and then the solvent was removed by distillation under reduced pressure to obtain a crude product of compound 2 (20.24 g) as a pale orange oily liquid. The obtained compound 2 was not purified, the yield was quantified, and the process proceeded to the next step.

[0227] 1H NMR (600 MHz, CDCl3) δ: 9.91 (s, 1H), 7.37-7.26 (m, 8H), 7.25-7.21 (m, 2H), 5.84 (d, J = 3.5 Hz, 1H), 4.71 (d, J = 12.0 Hz, 1H), 4.59(d, J=12.0 Hz, 1H), 4.60(dd, J=4.4, 3.5 Hz, 1H), 4.52(d, J=12.0 Hz, 1H), 4.46(d, J=12.0 Hz, 1H), 4.37(d, J=4.4 Hz, 1H), 3.67(d, J=11.4 Hz, 1H), 3.61(d, J=11.4 Hz, 1H), 1.60(s, 3H), 1.35(s, 3H)

[0228] (2) Synthesis of Compound 3

[0229]

[0230] The crude product (20.24 g) of compound 2 obtained in the previous process was co-boiled with toluene, dissolved in anhydrous dichloromethane (250 mL), and carbon tetrabromide (33.1 g, 100 mmol, 2.0 eq) was added. Next, triphenylphosphine (52.4 g, 200 mmol, 4.0 eq) was added at a temperature of 20°C or lower and stirred at room temperature for 1.5 hours, then triethylamine (41.5 mL, 300 mmol, 6.0 eq) was added at a temperature of 25°C or lower and stirred for 2 more hours. Hexane (200 mL) was added to this reaction solution and cooled on ice, the insoluble matter was filtered, and the solution was washed with ethyl acetate and dichloromethane (50 mL). The washing solution and the filtered solution were combined and removed by distillation under reduced pressure. The resulting residue was introduced into a silica gel pad (silica gel: 100 g) using a mixture of dichloromethane / hexane = 1 / 1 (v / v) (300 mL), followed by hexane / ethyl acetate = 1 / 2 (v / v) (300 mL), and then eluted with ethyl acetate (400 mL). The eluted solution was concentrated under reduced pressure, the resulting residue was washed by suspension with hexane / ethyl acetate = 1 / 1 (v / v) (200 mL), and the insoluble matter was filtered. The mother liquor was concentrated under reduced pressure, the resulting residue was washed by suspension with hexane / ethyl acetate = 2 / 1 (v / v) (100 mL), and the insoluble matter was filtered. The mother liquor was concentrated under reduced pressure, and a mixture (28.1 g) of compound 3 and triphenylphosphine oxide was obtained as a brown viscous liquid. The obtained compound 3 was not further purified, the yield was quantified, and the process proceeded to the next step.

[0231] 1H NMR (600 MHz, CDCl3) δ: 7.39-7.26 (m, 8H), 7.26-7.22 (m, 2H), 7.11 (s, 1H), 5.76 (d, J = 4.1 Hz, 1H), 4.72 (d, J = 12.0 Hz, 1H), 4.60(d, J=12.0 Hz, 1H), 4.59(d, J=12.0 Hz, 1H), 4.53(dd, J=4.7, 4.1 Hz, 1H), 4.42(d, J=12.0 Hz, 1H), 4.21(d, J=4.7 Hz, 1H), 3.83(d, J=11.4 Hz, 1H), 3.40(d, J=11.4 Hz, 1H), 1.59(s, 3H), 1.30(s, 3H)

[0232] (3) Synthesis of Compound 4

[0233]

[0234] Under a nitrogen atmosphere, a mixture (28.1 g) of compound 3 obtained in the previous process and triphenylphosphine oxide was azeotropically mixed with anhydrous tetrahydrofuran and dissolved in anhydrous tetrahydrofuran. At a temperature of -50°C or lower, n-butyllithium (1.6 M hexane solution, 71 mL, 110 mmol, 2.2 eq) was added dropwise over 30 minutes and stirred at -70°C for 1 hour. At the same temperature, water (100 mL) was added, ethyl acetate (400 mL), tap water (100 mL), and saturated saline solution (100 mL) were added, and extraction was performed to obtain organic layer I and aqueous layer I. The obtained aqueous layer I was extracted with ethyl acetate (100 mL) to obtain organic layer II. Organic layers I and II were combined, washed sequentially with a saturated aqueous ammonia chloride solution (200 mL) and a saturated saline solution (100 mL), dried with anhydrous sodium sulfate, concentrated under reduced pressure, and a crude product of compound 4 (21.2 g) was obtained as a brown liquid. The obtained compound 4 was not purified, the yield was quantified, and the process proceeded to the next step.

[0235] 1H NMR (600 MHz, CDCl3) δ: 7.41-7.27 (m, 8H), 7.22-7.19 (m, 2H), 5.70 (d, J = 3.5 Hz, 1H), 4.77 (d, J = 12.6 Hz, 1H), 4.69 (d, J = 12.6 Hz, 1H), 4.55(dd, J=4.7, 3.5 Hz, 1H), 4.52(d, J=12.3 Hz, 1H), 4.44(d, J=12.3 Hz, 1H), 4.16(d, J=4.7 Hz, 1H), 3.70(d, J=11.2 Hz, 1H), 3.55(d, J=11.3 Hz, 1H); 2.65(s, 1H), 1.72(s, 3H), 1.33(s, 3H)

[0236] (4) Synthesis of Compound 5

[0237]

[0238] To the solution of anhydrous acetic acid (94.5 mL, 1.00 mol) of the crude product (21.0 g) of Compound 4 obtained in the previous process, a solution of acetic acid (60 mL, 1.0 mol) of concentrated sulfuric acid (255 mg, 2.60 mmol, 0.05 eq) was added and stirred at room temperature for 7 hours. Acetic acid (57.2 mL, 1.00 mol) was added to the reaction mixture and stirred for 15 more hours. Under ice cooling, the reaction mixture was injected into a mixture of ethyl acetate (200 mL) and saturated sodium bicarbonate water (300 mL), the aqueous layer was extracted twice with ethyl acetate (100 mL), and the combined organic layer was washed sequentially with saturated sodium bicarbonate water (100 mL), tap water (100 mL), and saturated saline solution (100 mL). After drying with anhydrous sodium sulfate, the residue was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (silica gel: 100 g, hexane / ethyl acetate = 1 / 0 to 2 / 1 (v / v)), and compound 5 (17.7 g, 40.4 mmol, 4-step yield 82%) was obtained as an orange viscous liquid.

[0239] 1H NMR (600 MHz, CDCl3) δ: 7.36-7.27 (m, 8H), 7.26-7.16 (m, 2H), 6.19 (s, 1H), 5.29 (d, J = 4.7 Hz, 1H), 4.72 (d, J = 12.2 Hz, 1H), 4.59(d, J=12.2 Hz, 1H), 4.50(d, J=11.9 Hz, 1H), 4.46(d, J=4.7 Hz, 1H), 4.39(d, J=11.9 Hz, 1H), 3.67(d, J=11.2 Hz, 1H), 3.56(d, J=11.2 Hz, 1H), 2.65(s, 1H), 2.15(s, 3H), 1.80(s, 3H)

[0240] Example 2: Synthesis of T-Dibenzylates

[0241]

[0242] (1) Synthesis of Compound 6

[0243]

[0244] Under a nitrogen atmosphere, thymine (3.79 g, 30.1 mmol, 3.0 eq), N,O-bis(trimethylsilyl)acetamide (7.15 mL, 49.9 mmol, 5.0 eq), and trimethylsilyltriplate (2.71 mL, 15.0 mmol, 1.5 eq) were sequentially added to an anhydrous acetonitrile solution (50 mL) of compound 5 (4.38 g, 10.0 mmol), and heated under reflux for 5 hours. The reaction mixture, cooled to room temperature, was injected into saturated sodium bicarbonate water (300 mL) and extracted twice (300 mL, 200 mL) with ethyl acetate. After drying with anhydrous sodium sulfate, the solvent was removed by distillation under reduced pressure, and the resulting residue was purified by silica gel column chromatography (silica gel: 80 g, hexane / ethyl acetate = 2 / 1 to 1 / 2 (v / v)), and compound 6 (4.02 g, 7.97 mmol, 79.7%) was obtained as a pale yellow amorphous solid.

[0245] 1H NMR (600 MHz, CDCl3) δ: 8.45 (s, 1H), 7.37-7.29 (m, 9H), 7.26-7.22 (m, 2H), 6.28 (d, J = 4.8 Hz, 1H), 5.26 (dd, J = 6.0, 4.8 Hz, 1H), 4.67(d, J=11.7 Hz, 1H), 4.62(d, J=11.7 Hz, 1H), 4.50(d, J=11.3 Hz, 1H), 4.46(d, J=11.3 Hz, 1H), 4.40(d, J=6.0 Hz, 1H), 3.85(d, J=10.6 Hz, 1H), 3.62(d, J=10.6 Hz, 1H), 2.68(s, 1H), 2.11(s, 3H), 1.54(d, J=1.2 Hz, 3H)

[0246] (2) Synthesis of Compound 7

[0247]

[0248] Potassium carbonate (821 mg, 5.94 mmol, 3.0 eq) was added to a methanol solution (10 mL) of compound 6 (1.0 g, 2.0 mmol) and stirred at room temperature for 20 minutes. Tap water (10 mL) and ethyl acetate (10 mL) were added, and ethyl acetate (60 mL) was added to extract. The obtained organic layer was washed with a mixture of tap water (30 mL) and saturated saline solution (a small amount), followed by saturated saline solution (10 mL), dried with anhydrous sodium sulfate, concentrated under reduced pressure, and compound 7 (0.83 g, 1.8 mmol, 91%) was obtained as a white solid.

[0249] 1H NMR (600MHz, CDCl3) δ: 7.40-7.25(m, 11H), 6.07(d, J=5.3 Hz, 1H), 4.90(d, J=11.4 Hz, 1H), 4.68(d, J=11.4 Hz, 1H), 4.56(d, J=12.0) Hz, 1H), 4.55(d, J=12.0 Hz, 1H), 4.29(dd, J=5.9, 5.3 Hz, 1H), 4.23(d, J=5.9 Hz, 1H), 3.86(d, J=10.6 Hz, 1H), 3.70(d, J=10.6 Hz, 1H), 2.71(s, 1H), 1.59(d, J=0.9 Hz, 3H)

[0250] (3) Synthesis of Compound 8

[0251]

[0252] Under a nitrogen atmosphere, potassium tert-butoxide (303 mg, 2.70 mmol, 2.5 eq) was added to an anhydrous dimethyl sulfoxide solution (10 mL) of compound 7 (500 mg, 1.08 mmol) and stirred at room temperature for 2 hours. A saturated aqueous ammonia chloride solution (100 mL) was added and extracted with ethyl acetate (100 mL). The obtained organic layer was washed twice with tap water (50 mL) and then once with saturated saline solution (50 mL), dried with anhydrous sodium sulfate, concentrated under reduced pressure, and a crude product (435 mg) of compound 8 was obtained as a pale yellow amorphous solid. The obtained crude product of compound 8 was not purified and proceeded to the next process.

[0253] 1H NMR (600MHz, CDCl3) δ: 9.21(br s, 1H), 7.48(d, J=1.2 Hz, 1H), 7.38-7.23(m, 10H), 5.61(s, 1H), 4.72(s, 1H), 4.64(d, J=10.9 Hz, 1H), 4.66(d, J=12.0 Hz, 1H), 4.61(d, J=10.9 Hz, 1H), 4.56(d, J=12.0 Hz, 1H), 4.50(d, J=3.1 Hz, 1H), 4.04(d, J=3.1 Hz, 1H), 4.02(s, 1H), 4.00(d, J=11.3 Hz, 1H), 3.94(d, J=11.3 Hz, 1H), 1.59(d, J=1.2 Hz, 3H)

[0254] (4) Synthesis of Compound 9

[0255]

[0256] Under a nitrogen atmosphere, an anhydrous dichloromethane solution (50 mL) of compound 8 (2.67 g, 5.77 mmol) was dropped with an anhydrous dichloromethane solution (15 mL) of diiodomethane (7.73 g, 28.9 mmol, 5.0 eq) under ice cooling, and after washing with anhydrous dichloromethane (5 mL), diethyl zinc (1.0 M hexane solution, 28.9 mL, 28.9 mmol, 5.0 eq) was dropped over 15 minutes, stirred for 2 hours at the same temperature, and then for 20 hours at room temperature. At 10°C or below, 25 w / w% ammonia water (20 mL) and water (50 mL) were dropped over 5 minutes, and extracted twice with ethyl acetate (150 mL). The obtained organic layer was washed with tap water, then with saturated saline solution, dried with anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (silica gel: 60 g, chloroform / methanol = 1 / 0 to 9 / 1 (v / v)), and compound 9 (2.16 g, 4.53 mmol, 78.5%) was obtained as a yellow solid.

[0257] 1H NMR (600MHz, CDCl3) δ: 8.89(br s, 1H), 7.51(d, J=1.2 Hz, 1H), 7.38-7.27(m, 10H), 5.74(s, 1H), 4.70(d, J=11.7 Hz, 1H), 4.57(d, J=11.7 Hz, 1H), 4.56(s, 2H), 4.53(s, 1H), 4.04(s, 1H), 3.62(d, J=10.7 Hz, 1H), 3.50(d, J=10.7 Hz, 1H), 1.62(d, J=1.2 Hz, 3H), 1.03-0.96(m, 1H); 0.96-0.89(m, 1H), 0.75-0.65(m, 2H)

[0258] Compound 9 can be synthesized from Compound 1 through 11 process transformations by using the method described in WO2015 / 125783, which is a conventional synthesis method. Meanwhile, by using the method of Example 1 and Example 2, the transformation from Compound 1 to Compound 9 can be performed in 8 process steps, thereby enabling a reduction in the number of process steps.

[0259] Example 3: Synthesis of G-Dibenzylates (Part 1)

[0260]

[0261] (1) Synthesis of Compound 10

[0262]

[0263] Under a nitrogen atmosphere, N,O-bis(trimethylsilyl)acetamide (1.5 mL, 8.3 mmol, 2.0 eq) and trimethylsilyltriplate (1.8 mL, 13 mmol, 3.0 eq) were sequentially added to a 1,2-dichloroethane (20 mL) solution of compound 5 (1.86 g, 4.24 mmol) and ON,N-diphenylcarbamoyl-N-isobutyrylguanine (1.94 g, 4.66 mmol, 1.1 eq) under ice cooling, and heated under reflux for 2.5 hours. The reaction mixture was cooled to room temperature, ice-cooled, saturated sodium bicarbonate (50 mL) was added, and extracted twice (100 mL, 50 mL) with chloroform. The combined organic layer was washed with saturated saline (20 mL), dried with anhydrous sodium sulfate, and then concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (silica gel: 45 g, chloroform / ethyl acetate = 1 / 0 to 85 / 15 (v / v)), and compound 10 (1.78 g, 2.24 mmol, 52.8%) was obtained as a pale yellow amorphous solid.

[0264] 1H NMR (600 MHz, CDCl3) δ: 8.09 (s, 1H), 7.88 (s, 1H), 7.39-7.20 (m, 20H), 6.23 (d, J = 3.8 Hz, 1H), 5.67 (dd, J = 5.9, 3.8 Hz, 1H), 4.94(d, J=5.9 Hz, 1H), 4.78(d, J=11.7 Hz, 1H), 4.67(d, J=11.7 Hz, 1H), 4.52(d, J=12.1 Hz, 1H), 4.47(d, J=12.1 Hz, 1H), 3.81(d, J=10.9 Hz, 1H), 3.68(d, J=10.9 Hz, 1H), 3.07-2.84(m, 1H), 2.70(s, 1H), 2.09(s, 3H), 1.24(d, J=6.8 Hz, 3H), 1.24(d, J=6.8 Hz, 3H)

[0265] (2) Synthesis of Compound 12

[0266]

[0267] Under a nitrogen atmosphere, potassium tert-butoxide (70.6 mg, 0.629 mmol, 5.0 eq) was added to a solution of anhydrous dimethyl sulfoxide (1 mL) of compound 10 (100 mg, 0.126 mmol) and stirred at room temperature for 30 minutes. Methanol (8.0 μL, 0.20 mmol, 1.6 eq) was added and stirred for 3 more hours. Methanol (4.0 μL, 0.10 mmol, 0.8 eq) and potassium tert-butoxide (37.5 mg, 0.334 mmol, 2.7 eq) were added and stirred for 16 more hours. Ethyl acetate (10 mL) and tap water (10 mL) were added, and the mixture was extracted twice with ethyl acetate. The combined organic layer was washed twice with a 1M aqueous hydrochloric acid solution (20 mL), followed by washing with a saturated saline solution (20 mL), dried with anhydrous sodium sulfate, concentrated under reduced pressure, and a mixture of compound 12 and diphenylamine (76.2 mg, purity 72%, yield 78%) by integration ratio of 1H-NMR was obtained as a light brown amorphous solid.

[0268] 1H NMR (600MHz, CDCl3) δ: 12.12 (br s, 1H), 9.48 (br s, 1H), 7.81(s, 1H), 7.39-7.18(m, 10H), 5.77(s, 1H), 4.68(d, J=12.3 Hz, 1H), 4.62(d, J=12.3 Hz, 1H), 4.62(s, 1H), 4.59(d, J=11.7 Hz, 1H), 4.53(d, J=11.7 Hz, 1H), 4.50(d, J=2.9 Hz, 1H), 4.28(s, 1H), 4.12(d, J=2.9 Hz, 1H), 3.94(d, J=11.4 Hz, 1H), 3.90(d, J=11.4 Hz, 1H), 2.71-2.65(m, 1H), 1.26(d, J=6.2 Hz, 3H), 1.25(d, J=6.2 Hz, 3H)

[0269] (3) Synthesis of Compound 13

[0270]

[0271] Under a nitrogen atmosphere, N,N-diisopropylethylamine (0.10 mL, 0.59 mmol, 3.0 eq) and N,N-diphenylcarbamoyl chloride (56 mg, 0.24 mmol, 1.2 eq) were sequentially added to an anhydrous pyridine (0.8 mL) solution of Compound 12 (110 mg, 0.197 mmol) and stirred at room temperature for 6 hours. Tap water (0.1 mL) was added, and the solvent was removed by distillation under reduced pressure, followed by two azeotropic reactions with toluene. The residue was dissolved in ethyl acetate, washed sequentially with a 1 M aqueous hydrochloric acid solution, saturated sodium bicarbonate water, and saturated saline solution, dried with anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was two azeotropic reactions with toluene, and the crude product (178 mg) of Compound 13 was obtained as a red amorphous solid. The obtained compound 13 was not purified and proceeded to the next process.

[0272] 1H NMR (600MHz, CDCl3) δ: 8.18(s, 1H), 7.98(br s, 1H), 7.50-7.14(m, 20H), 5.95(s, 1H), 4.97(s, 1H), 4.67(d, J=12.3 Hz, 1H), 4.62(d, J=12.3 Hz, 1H), 4.59-4.55(m, 2H), 4.52(d, J=3.2 Hz, 1H), 4.28(s, 1H), 4.12(d, J=3.2 Hz, 1H), 3.94(d, J=11.3 Hz, 1H), 3.89(d, J=11.3 Hz, 1H); 3.06-2.90(m, 1H), 1.26-1.24(m, 6H)

[0273] (4) Synthesis of Compound 14

[0274]

[0275] Under a nitrogen atmosphere, diethyl zinc (1 M hexane solution, 2.0 mL, 2.0 mmol, 10 eq) was added to ice-cooled anhydrous dichloromethane (3 mL), then an anhydrous dichloromethane (1 mL) solution of trifluoroacetic acid (230 mg, 2.02 mmol, 10 eq) was added dropwise over 5 minutes and stirred at the same temperature for 30 minutes, then an anhydrous dichloromethane (1 mL) solution of diiodomethane (542 mg, 2.02 mmol, 10 eq) was added dropwise over 5 minutes and stirred further at the same temperature for 30 minutes. To this solution, an anhydrous dichloromethane (0.5 mL, including further washed with 0.5 mL) solution of the crude product (178 mg) of compound 13 was added dropwise and stirred at the same temperature for 3 hours. 0.5 M aqueous hydrochloric acid solution (10 mL) and chloroform (15 mL) were added and vigorously stirred at room temperature for 1 hour. The resulting solution was separated into an aqueous layer and an organic layer, the aqueous layer was further extracted with chloroform, combined with the previous organic layer, washed with saturated saline solution, dried with anhydrous sodium sulfate, and then concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (silica gel: 14 g, hexane / ethyl acetate / methanol = 90 / 5 / 5 to 75 / 20 / 5 (v / v / v)), and compound 14 (86.4 mg, 0.113 mmol, 57.2%) was obtained as a reddish-brown viscous liquid.

[0276] 1H NMR (600 MHz, CDCl3) δ: 8.19 (s, 1H), 7.97 (s, 1H), 7.51-7.20 (m, 20H), 6.10 (s, 1H), 4.78 (s, 1H), 4.62 (d, J = 11.9 Hz, 1H), 4.59-4.53(m, 1H), 4.55(d, J=11.9 Hz, 1H), 4.30(s, 1H), 3.64(d, J=11.0 Hz, 1H), 3.54(d, J=11.0 Hz, 1H), 3.08-2.95(m, 1H), 1.25(d, J=6.9 Hz, 3H), 1.25(d, J=6.9 Hz, 3H), 1.01-0.91(m, 2H), 0.88-0.83(m, 1H), 0.76-0.70(m, 1H)

[0277] (5) Synthesis of the compound shown in formula (a)

[0278]

[0279] It was confirmed that compound 14 can be easily converted into the compound shown in formula (a) by treating it with a weak acid (such as a carboxylic acid).

[0280] A compound shown in the following formula (a) that can be used as a precursor of scpBNA in the same way as compound 14:

[0281]

[0282] The compound can be synthesized from compound 1 through 12 process transformations by using the method described in WO2015 / 125783, which is a conventional synthesis method. Meanwhile, by using the method of Example 1 and Example 3, the transformation from compound 1 to the compound shown in formula (a) can be performed in 9 process steps, thereby enabling a reduction in the number of process steps.

[0283] Example 4: Synthesis of G-Dibenzylates (part 2)

[0284]

[0285] (1) Synthesis of Compound 15

[0286]

[0287] Under a nitrogen atmosphere, N-isobutyrylguanine (1.94 g, 8.77 mmol, 1.2 eq), N,O-bis(trimethylsilyl)acetamide (3.14 mL, 21.9 mmol, 3.0 eq), and trimethylsilyltriplate (2.64 mL, 14.6 mmol, 2.0 eq) were sequentially added to a 1,2-dichloroethane (100 mL) solution of compound 5 (4.0 g, 80% purity, 7.3 mmol) under ice cooling, stirred at room temperature for 17 hours, then heated to 50°C and stirred for 1 hour. N,O-bis(trimethylsilyl)acetamide (3.14 mL, 21.9 mmol, 3.0 eq) was added and stirred for 1 hour at the same temperature, then heated under reflux for 2 hours, cooled to room temperature, and stirred for 3 hours. Under ice cooling, saturated sodium bicarbonate (50 mL) was added and extracted three times with chloroform. The combined organic layer was dried with anhydrous sodium sulfate and then concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (silica gel: 60 g, hexane / ethyl acetate / chloroform / methanol = 3 / 3 / 1 / 0 to 3 / 3 / 1 / 0.4 (v / v / v / v)), and a mixture of compound 15 and compound 16 (3.00 g, compound 15:compound 16 = 85:15 from 1H-NMR, 4.25 mmol, yield 58%) was obtained as a clear brown amorphous solid.

[0288] 1H NMR(600MHz, CDCl3) δ: 12.21(s, 0.85H), 12.06(s, 0.15H), 9.67 (br s, 0.15H), 8.19 (br s, 0.85H), 8.19(s, 0.15H), 7.83(s, 0.85H), 7.36-7.30(m, 8H), 7.26-7.24(m, 2H), 6.50(d, J=3.2 Hz, 0.15H), 6.16(d, J=5.0 Hz, 0.85H), 5.63(dd, J=6.0, 3.2 Hz, 0.15H), 5.61(dd, J=5.9, 5.0 Hz, 0.85H), 4.73(d, J=11.6 Hz, 0.85H), 4.64(d, J=11.4 Hz, 0.15H), 4.64(d, J=5.9 Hz, 0.85H), 4.59(d, J=11.6 Hz, 0.85H), 4.57(d, J=6.0 Hz, 0.15H), 4.56(d, J=11.4 Hz, 0.15H), 4.55(d, J=11.9 Hz, 0.85H), 4.49-4.47(m, 0.30H), 4.48(d, J=11.9 Hz, 0.85H), 3.81(d, J=10.9 Hz, 0.15H), 3.79(d, J=10.9 Hz, 0.85H), 3.68(d, J=10.9 Hz, 0.85H), 3.58(d, J=10.9 Hz, 0.15H), 2.77 (dq, J=6.9, 6.9 Hz, 0.85H), 2.71(s, 0.85H), 2.70(s, 0.15H), 2.50 (dq, J=6.9, 6.9 Hz, 0.15H), 2.14(s, 0.45H), 2.08(s, 2.55H), 1.28(d, J=6.9 Hz, 0.45H), 1.27(d, J=6.9 Hz, 0.45H), 1.23(d, J=6.9 Hz, 2.55H), 1.22(d, J=6.9 Hz, 2.55H)

[0289] (2) 화합물 17의 합성

[0290]

[0291] Potassium carbonate (2.07 g, 15.0 mmol, 3.0 eq) was added to a methanol (30 mL) solution of a mixture of Compound 15 and Compound 16 (3.0 g, 5.0 mmol, Compound 15:Compound 16 = 85:15) under ice cooling, and stirred for 30 minutes at the same temperature. Potassium carbonate (0.50 g, 3.6 mmol, 0.72 eq) was added and stirred for another 15 minutes. After adding a saturated aqueous ammonia chloride solution, the mixture was extracted with ethyl acetate, the organic layer was washed sequentially with tap water and saturated saline solution, and dried with anhydrous sodium sulfate. The solvent was removed by distillation under reduced pressure, and the resulting residue was purified by silica gel column chromatography (silica gel: 30 g, chloroform / ethyl acetate = 1 / 0 to 4 / 1 (v / v)), and a mixture of compound 17 and compound 17' (2.41 g, compound 17: compound 17' = 85: 15, 4.32 mmol, yield 86%) was obtained as a white amorphous solid.

[0292] 1H NMR(600MHz, CDCl3) δ: 12.50 (br s, 0.15H), 12.25 (br s, 0.85H), 9.82 (br s, 0.15H), 8.99 (br s, 0.85H), 8.12(s, 0.85H), 7.88(s, 0.15H), 7.42-7.21(m, 10H), 6.31(d, J=4.4 Hz, 0.85H), 6.02(d, J=4.7 Hz, 0.15H), 4.91(d, J=11.4 Hz, 0.15H), 4.82(d, J=11.4 Hz, 0.85H), 4.78(d, J=11.4 Hz, 0.15H), 4.70(d, J=11.4 Hz, 0.85H), 4.65-4.62(m, 0.15H), 4.59(d, J=12.0 Hz, 0.85H), 4.55(d, J=12.0 Hz, 0.15H), 4.55(d, J=12.0 Hz, 0.85H), 4.55-4.53(m, 0.15H), 4.54 (ddd, J=6.6, 6.2, 4.4 Hz, 0.85H), 4.49(d, J=12.0 Hz, 0.15H), 4.40(d, J=6.2 Hz, 0.85H), 3.87-3.85(m, 0.15H), 3.85(d, J=10.4 Hz, 0.85H), 3.78(d, J=10.9 Hz, 0.15H), 3.71(d, J=10.9 Hz, 0.15H), 3.69(d, J=10.4 Hz, 0.85H), 3.52(d, J=6.6 Hz, 0.85H), 2.81 (dq, J=6.9, 6.9 Hz, 0.85H), 2.74(s, 0.85H), 2.73(s, 0.15H), 2.62 (dq, J=6.9, 6.9 Hz, 0.15H), 1.26(d, J=6.9 Hz, 2.55H), 1.26(d, J=6.9 Hz, 2.55H), 1.22(d, J=6.9 Hz, 0.45H), 1.22(d, J=6.9 Hz, 0.45H)

[0293] (3) 화합물 18의 합성

[0294]

[0295] Under a nitrogen atmosphere, potassium tert-butoxide (302 mg, 2.69 mmol, 1.5 eq) was added to a solution of anhydrous dimethyl sulfoxide (20 mL) of a mixture of compound 17 and compound 17' (1.00 g, 1.79 mmol, compound 17:compound 17'=85:15) and stirred at room temperature for 1 hour. After adding potassium tert-butoxide (150 mg, 1.34 mmol, 0.75 eq) and stirring for 30 minutes, potassium tert-butoxide (273 mg, 2.43 mmol, 1.4 eq) was added and stirred for 3 more hours. Under ice cooling, ethyl acetate (150 mL) and tap water (50 mL) were added, and the mixture was extracted twice with ethyl acetate. The combined organic layer was washed twice with tap water, followed by washing with saturated saline solution, dried with anhydrous sodium sulfate, concentrated under reduced pressure, and a crude mixture of compound 18 and compound 18' (904 mg, compound 18: compound 18' = 85:15) was obtained as a light brown amorphous solid.

[0296] 1H NMR (600MHz, CDCl3) δ: 12.29 (br s, 0.85H), 12.12 (br s, 0.15H), 9.96 (br s, 0.15H), 8.85 (br s, 0.85H), 8.20(s, 0.15H), 7.82(s, 0.85H), 7.37-7.16(m, 10H), 6.15(s, 0.15H), 5.75(s, 0.85H), 4.71-4.47(m, 6H), 4.26(s, 0.85H), 4.18(s, 0.15H), 4.11(d, J=3.23 Hz, 0.85H), 4.06(d, J=3.23, 0.15H), 3.96(d, J=10.9 Hz, 0.15H), 3.93(d, J=11.2 Hz, 0.85H), 3.90(d, J=10.9 Hz, 0.15H), 3.89(d, J=11.2 Hz, 0.85H), 2.78 (dq, J=6.9, 6.9 Hz, 0.15H), 2.67 (dq, J=6.9, 6.9 Hz, 0.85H), 1.28(d, J=6.9 Hz, 2.55H), 1.27(d, J=6.9 Hz, 0.45H), 1.27(d, J=6.9 Hz, 2.55H), 1.25(d, J=6.9 Hz, 0.45H)

[0297] (4) Synthesis of Compound 19

[0298] The process (3) of Example 3 was carried out under the same conditions.

[0299] (5) Synthesis of Compound 20

[0300] The process (4) of Example 3 was carried out under the same conditions.

[0301] As in Example 3, it can be seen that scpBNA with a compound having a guanine backbone can be obtained regardless of the presence or absence of a protecting group.

[0302] Example 5: Synthesis of A-Dibenzyls (Part 1)

[0303]

[0304] (1) Synthesis of Compound 21

[0305]

[0306] Under a nitrogen atmosphere, N6-benzoyladenine (1.60 g, 6.69 mmol, 1.1 eq) was added to an acetonitrile solution (80 mL) of compound 5 (3.32 g, 80% purity, 6.08 mmol), and then N,O-bis(trimethylsilyl)acetamide (2.61 mL, 18.2 mmol, 3.0 eq) and trimethylsilyltriplate (1.65 mL, 9.12 mmol, 1.5 eq) were added sequentially under ice cooling, and the mixture was stirred at room temperature for 18 hours. After heating and refluxing for 5.5 hours, the mixture was cooled and stirred at room temperature for 18 hours, then heated and refluxed for 6 hours, cooled back to room temperature, and stirred at room temperature for 20 hours. Under ice cooling, saturated sodium bicarbonate was added and extracted with ethyl acetate, after which the organic layer was washed sequentially with tap water and saturated saline solution, dried with anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (silica gel: 60 g, chloroform / ethyl acetate = 1 / 0 to 6 / 4 (v / v)), and compound 21 (3.11 g, 5.04 mmol, yield 82.8%) was obtained as a light brown amorphous solid.

[0307] 1H NMR (600 MHz, CDCl3) δ: 8.95 (s, 1H), 8.74 (s, 1H), 8.21 (s, 1H), 8.04-8.00 (m, 2H), 7.64-7.59 (m, 1H), 7.56-7.51 (m, 2H), 7.38-7.27(m, 8H), 7.23-7.19(m, 2H), 6.40(d, J=4.1 Hz, 1H), 5.82(dd, J=5.6, 4.1 Hz, 1H), 4.76(d, J=5.6 Hz, 1H), 4.72(d, J=11.7) Hz, 1H), 4.66(d, J=11.7 Hz, 1H), 4.49(d, J=12.0 Hz, 1H), 4.44(d, J=12.0 Hz, 1H), 3.81(d, J=10.9 Hz, 1H), 3.63(d, J=10.9 Hz, 1H), 2.72(s, 1H), 2.11(s, 3H)

[0308] (2) Synthesis of Compound 22

[0309]

[0310] Under ice cooling, potassium carbonate (1.00 g, 7.24 mmol, 3.0 eq) was added to a methanol solution (20 mL) of compound 21 (1.50 g, 2.43 mmol) and stirred for 30 minutes at the same temperature. After adding a saturated aqueous ammonia chloride solution and extracting twice with ethyl acetate, the combined organic layer was washed with saturated saline solution and dried with anhydrous sodium sulfate. The solvent was removed by distillation under reduced pressure, and a crude product (1.50 g) of compound 22 was obtained as a pale orange amorphous solid. The obtained compound 22 was not purified and proceeded immediately to the next reaction.

[0311] 1H NMR (600 MHz, CDCl3) δ: 8.91 (s, 1H), 8.74 (s, 1H), 8.19 (s, 1H), 8.03-8.00 (m, 2H), 7.64-7.60 (m, 1H), 7.56-7.51 (m, 2H), 7.43-7.29(m, 8H), 7.25-7.22(m, 2H), 6.23(d, J=4.4 Hz, 1H), 4.92(d, J=11.4 Hz, 1H), 4.81 (ddd, J=6.7, 5.9, 4.4 Hz, 1H), 4.72(d, J=11.4 Hz, 1H), 4.60(d, J=5.9 Hz, 1H), 4.56(d, J=12.0 Hz, 1H), 4.51(d, J=12.0 Hz, 1H), 3.83(d, J=10.6 Hz, 1H), 3.70(d, J=10.6 Hz, 1H), 3.33(d, J=6.7 Hz, 1H), 2.76(s, 1H)

[0312] (3) Synthesis of Compound 23

[0313]

[0314] Under a nitrogen atmosphere, potassium tert-butoxide (545 mg, 4.85 mmol, 2.0 eq) was added to an anhydrous dimethyl sulfoxide solution (30 mL) of the crude product (1.50 g) of Compound 22 obtained in the previous process, and stirred at room temperature for 2.5 hours. Saturated aqueous ammonium chloride solution and ethyl acetate were added, and after extraction twice with ethyl acetate, the combined organic layer was washed sequentially with tap water and saturated saline solution, dried with anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The resulting residue was purified on a silica gel pad (NH2 silica gel, hexane / ethyl acetate / methanol = 8 / 8 / 1), and Compound 23 (1.18 g, 2.05 mmol, 2-process yield 84.4%) was obtained as a brown viscous liquid.

[0315] 1H NMR (600MHz, CDCl3) δ: 9.04(s, 1H), 8.75(s, 1H), 8.26(s, 1H), 8.04(d, J=7.5 Hz, 2H), 7.63 (t, J=7.6 Hz, 1H), 7.54(dd, J=7.6, 7.5 Hz, 2H), 7.41-7.28(m, 6H), 7.26-7.17(m, 4H), 6.06(s, 1H), 4.98(s, 1H), 4.69(d, J=12.2 Hz, 1H), 4.64(d, J=12.2 Hz, 1H), 4.61(d, J=12.0 Hz, 1H); 4.58(d, J=12.0 Hz, 1H), 4.56(d, J=3.2 Hz, 1H), 4.36(s, 1H), 4.15(d, J=3.2 Hz, 1H), 3.98(d, J=11.2 Hz, 1H), 3.92(d, J=11.2 Hz, 1H)

[0316] (4) Synthesis of Compound 24

[0317]

[0318] Under a nitrogen atmosphere, diethyl zinc (1M hexane solution, 2.4 mL, 2.4 mmol, 10 eq) was added to ice-cooled anhydrous dichloromethane (2.8 mL), then an anhydrous dichloromethane (1 mL) solution of trifluoroacetic acid (274 mg, 2.40 mmol, 10 eq) was added dropwise over 5 minutes and stirred at the same temperature for 30 minutes, then an anhydrous dichloromethane (1 mL) solution of diiodomethane (643 mg, 2.40 mmol, 10 eq) was added dropwise over 5 minutes and stirred at the same temperature for 30 minutes to prepare a zinc carbenoid solution. Under a nitrogen atmosphere, zinc carbenoid solution (720 μL) was added dropwise to an anhydrous dichloromethane (2.0 mL) solution of ice-cooled compound 23 (138 mg, 0.240 mmol). After stirring at the same temperature for 1.5 hours, zinc carbenoid solution (720 μL) was added dropwise, and after stirring for 1 hour, zinc carbenoid solution (720 μL) was added dropwise. After 30 minutes and 75 minutes, zinc carbenoid solution (1.5 mL each) was further added dropwise and stirred for 1.5 hours. Saturated aqueous ammonia chloride solution and chloroform were added, and after vigorous stirring at room temperature for 30 minutes, the resulting solution was separated into an aqueous layer and an organic layer, and the aqueous layer was also extracted with chloroform. The combined organic layer was washed with saturated saline solution, dried with anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure to obtain the residue. The ratio of compound 24 to compound 25 in the obtained residue was 3:1 (calculated from LC / MS and 1H-NMR).

[0319] Example 6: Synthesis of A-Dibenzyls (part 2)

[0320]

[0321] (1) Synthesis of Compound 26

[0322]

[0323] Under a nitrogen atmosphere, chlorotrimethylsilane (11 mL, 87.1 mmol, 29 eq) was added to a bis(trimethylsilyl)amine (25 mL) solution of adenine (1.01 g, 7.47 mmol, 2.5 eq), and heated under reflux for 5 hours. After cooling and concentrating under reduced pressure, the resulting residue was dissolved in 1,2-dichloroethane (5 mL) under a nitrogen atmosphere, a dichloroethane (10 mL) solution of compound 5 (1.32 g, 3.00 mmol) was added, followed by the addition of trimethylsilyltriplate (2.70 mL, 14.9 mmol, 5.0 eq), and stirred at room temperature for 17.5 hours. Saturated sodium bicarbonate (200 mL) was added, and the mixture was extracted twice with ethyl acetate (200 mL). The organic layer was then washed with saturated saline solution, dried with anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (silica gel: 60 g, hexane / ethyl acetate / methanol = 75 / 20 / 5 to 45 / 50 / 5 (v / v / v)), and compound 26 (1.32 g, 2.57 mmol, yield 85.7%) was obtained as a white waxy solid.

[0324] 1H NMR (600MHz, CDCl3) δ: 8.29(s, 1H), 7.96(s, 1H), 7.38-7.27(m, 8H), 7.24-7.20(m, 2H), 6.32(d, J=4.1 Hz, 1H), 5.79(dd, J=5.9, 4.1 Hz, 1H), 5.74 (br s, 2H), 4.76(d, J=5.9 Hz, 1H), 4.70(d, J=11.7 Hz, 1H), 4.65(d, J=11.7 Hz, 1H), 4.50(d, J=12.0 Hz, 1H), 4.44(d, J=12.0 Hz, 1H); 3.80(d, J=10.7 Hz, 1H), 3.63(d, J=10.7 Hz, 1H), 2.71(s, 1H), 2.10(s, 3H)

[0325] (2) Synthesis of Compound 27

[0326]

[0327] Potassium tert-butoxide (432 mg, 3.85 mmol, 5.0 eq) was added to a tert-butyl alcohol solution (4 mL) of compound 26 (395 mg, 0.769 mmol) and stirred at room temperature for 1.5 hours. Potassium tert-butoxide (480 mg, 4.28 mmol, 5.6 eq) was added and stirred for 1 hour, after which potassium tert-butoxide (300 mg, 2.67 mmol, 3.5 eq) was added and stirred for another hour. Tap water (6 mL) and saturated saline solution (12 mL) were added, and the mixture was extracted twice with ethyl acetate. The combined organic layer was then washed with saturated saline solution, dried with anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure to obtain a crude product (315 mg) of compound 27 as an orange amorphous solid. The crude product of the obtained compound 27 was not purified and proceeded to the next process.

[0328] 1H NMR (600MHz, CDCl3) δ: 8.31(s, 1H), 8.00(s, 1H), 7.30-7.22(m, 10H), 5.99(s, 1H), 5.78(br s, 2H), 4.97(s, 1H), 4.69(d, J=12.2 Hz, 1H), 4.63(d, J=12.2 Hz, 1H), 4.59(s, 2H), 4.54(d, J=2.9 Hz, 1H), 4.35(s, 1H), 4.14(d, J=2.9 Hz, 1H), 3.97(d, J=11.3) Hz, 1H), 3.92(d, J=11.3 Hz, 1H)

[0329] (3) Synthesis of Compound 28

[0330]

[0331] Under a nitrogen atmosphere, sodium iodide (318 mg, 2.12 mmol, 10 eq) was added to an N,N-dimethylformamide solution (2 mL) of compound 27 (100 mg, 0.212 mmol), and then benzylchloromethyl ether (300 μL, 2.16 mmol, 10 eq) was added under ice cooling and stirred at room temperature for 3 hours. Saturated sodium bicarbonate water (6 mL) and tap water (12 mL) were added, and the mixture was extracted twice with ethyl acetate. The combined organic layer was then washed sequentially with a 15 w / w% aqueous sodium thiosulfate solution and saturated saline solution, and dried with anhydrous sodium sulfate. The solvent was removed by distillation under reduced pressure to obtain a crude product (390 mg) of compound 28 as an orange oily liquid. The obtained crude product of compound 28 was not purified and proceeded to the next process.

[0332] (4) Synthesis of Compound 29

[0333]

[0334] Under a nitrogen atmosphere, benzoyl chloride (120 μL, 1.03 mmol, 4.9 eq) was added to a pyridine solution (3 mL) of the crude product (390 mg) of compound 28 obtained in the previous process, and stirred at room temperature for 5 hours. Tap water (20 mL) was added, and after extraction twice with ethyl acetate, the combined organic layer was washed sequentially with a 1 M aqueous hydrochloric acid solution, tap water, and saturated saline solution, dried with anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The obtained residue was purified by silica gel column chromatography (NH2 silica gel: 20 g, hexane / ethyl acetate / methanol = 85 / 10 / 5 to 70 / 25 / 5 (v / v / v)), and compound 29 (60.5 mg, 0.0870 mol, yield 41.0%) was obtained as a pale yellow oily liquid.

[0335] 1H NMR(600MHz, CDCl3) δ: 8.18-8.15(m, 2H), 8.02(s, 1H), 7.98(s, 1H), 7.53-7.49(m, 1H), 7.44-7.18(m, 17H), 5.89(s, 1H), 5.72(d, J=10.7 Hz, 1H), 5.70(d, J=10.7 Hz, 1H), 4.82(d, J=12.0 Hz, 1H), 4.84(d, J=12.0 Hz, 1H), 4.74(s, 1H), 4.63(d, J=12.6 Hz, 1H), 4.58(d, J=12.6 Hz, 1H), 4.56(d, J=12.0 Hz, 1H), 4.52(d, J=12.0 Hz, 1H), 4.51(d, J=3.1 Hz, 1H), 4.29(s, 1H), 4.08(d, J=3.1 Hz, 1H), 3.88(d, J=11.2 Hz, 1H), 3.83(d, J=11.2 Hz, 1H)

[0336] (5) 화합물 29의 합성

[0337]

[0338] Under a nitrogen atmosphere, sodium iodide (241 mg, 1.61 mmol, 2.2 eq) was added to a 1.5 mL N,N-dimethylacetamide solution (345 mg, 0.732 mmol) of compound 27 (345 mg, 0.732 mmol), and then benzylchloromethyl ether (250 μL, 1.80 mmol, 2.5 eq) was added under ice cooling and stirred for 2 hours at the same temperature. At the same temperature, benzylchloromethyl ether (35 μL, 0.25 mmol, 0.34 eq) was added and stirred for another 1.5 hours. At the same temperature, triethylamine (2.0 mL, 14.4 mmol, 20 eq) and benzoyl chloride (400 μL, 3.44 mmol, 4.7 eq) were added and stirred for 2 hours. Ethyl acetate (30 mL) and tap water (10 mL) were added and stirred, then the organic layer and the water layer were separated. The organic layer was washed sequentially with a 15 w / w% sodium thiosulfate aqueous solution, tap water, and saturated saline solution, dried with anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The resulting residue was purified by silica gel column chromatography (NH2 silica gel: 30 g, hexane / ethyl acetate / methanol = 90 / 5 / 5 to 85 / 10 / 5 (v / v / v)), and compound 29 (462.6 mg, purity 70%, 0.465 mmol, yield 63.6%) was obtained as a pale yellow oily liquid.

[0339] (6) Synthesis of Compound 30

[0340]

[0341] Under a nitrogen atmosphere, diethyl zinc (1M hexane solution, 0.25 mL, 0.25 mmol, 7.0 eq) was added to ice-cooled anhydrous dichloromethane (0.25 mL), then an anhydrous dichloromethane (0.25 mL) solution of trifluoroacetic acid (30.0 mg, 0.263 mmol, 7.3 eq) was added dropwise at a rate of 1 minute and stirred at the same temperature for 30 minutes, then an anhydrous dichloromethane (0.25 mL) solution of diiodomethane (67.4 mg, 0.259 mmol, 7.0 eq) was added dropwise at a rate of 1 minute and stirred further at the same temperature for 30 minutes to prepare a zinc carbenoid solution. To this solution, a solution of anhydrous dichloromethane (0.5 mL, and further washed with 0.5 mL) of compound 29 (25.0 mg, 0.0359 mmol) was added dropwise and stirred at the same temperature for 4.5 hours. Saturated aqueous ammonia chloride solution (20 mL) and chloroform (20 mL) were added and vigorously stirred at room temperature for 30 minutes, after which the resulting solution was separated into an aqueous layer and an organic layer, and the aqueous layer was also extracted with chloroform. The combined organic layer was washed with saturated saline solution, dried with anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The obtained residue was purified by silica gel column chromatography (silica gel: 10 g, hexane / ethyl acetate / methanol = 80 / 15 / 5 (v / v / v)), and compound 30 (20.0 mg, 0.0282 mmol, yield 78.5%) was obtained as a pale yellow oily liquid.

[0342] 1H NMR (600 MHz, CDCl3) δ: 8.19-8.15 (m, 2H), 8.03 (s, 1H), 7.97 (s, 1H), 7.52-7.48 (m, 1H), 7.44-7.21 (m, 17H), 6.04 (s, 1H), 5.72(d, J=10.3 Hz, 1H), 5.70(d, J=10.3 Hz, 1H), 4.84(d, J=12.0 Hz, 1H), 4.82(d, J=12.0 Hz, 1H), 4.59-4.52(m, 4H), 4.52(s, 1H), 4.27(s, 1H), 3.54(d, J=11.2 Hz, 1H), 3.47(d, J=11.2 Hz, 1H), 1.02-0.65(m, 4H)

[0343] (7) Synthesis of the compound shown in formula (b)

[0344]

[0345] It was confirmed that compound 30 can be easily converted into the compound shown in formula (b) by treating it with a weak acid (carboxylic acid, silica gel, etc.).

[0346] Compound shown in formula (b) below, which can be used as a precursor of scpBNA, similar to compound 30

[0347]

[0348] The compound can be synthesized from compound 1 through 12 process transformations by using the method described in WO2015 / 125783, which is a conventional synthesis method. Meanwhile, by using the method of Example 1 and Example 6, the transformation from compound 1 to the compound shown in formula (b) can be performed in 9 process steps, thereby enabling a reduction in the number of process steps.

[0349] [Industrial Applicability]

[0350] According to the present invention, it is possible to efficiently produce nucleosides of spirocyclopropylene bridge nucleic acid (scpBNA), so they can be advantageously used, for example, in the field of nucleic acid medicine.

Claims

Claim 1 A method for manufacturing a compound represented by the following formula (III), comprising a process of cyclopropanizing a compound represented by the following formula (II), wherein the cyclopropanizing process comprises a process of post-treating the reaction solution with ammonia: (In the above formula (II), X represents a nucleobase portion that may have one or more any substituents selected from group α, wherein group α is composed of a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an alkylthio group having 1 to 5 carbon atoms, an amino group, an amino group protected by a protecting group for nucleic acid synthesis, an amino group substituted with an alkyl group having 1 to 5 carbon atoms, and a halogen atom; R 1 and R 2 Each independently comprises a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4 [each independently represents a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, a C1–5 alkoxy group, a C1–5 alkylthio group, a C1–6 cyanoalkoxy group, or an amino group substituted with a C1–6 alkyl group;R 5 ...represents a hydrogen atom; a halogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with an aryl group having 3 to 12 carbon atoms that may contain a heteroatom and may also form a branch or ring; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may contain a heteroatom; or a silyl group. (In the above equation (III), X, R 1 , R 2 and R 5 is as stated above, and R 5' is R 5 Independent of and R 5 Defined identically to ). Claim 2 A method of manufacturing in which X has a pyrimidine skeleton, according to claim 1. Claim 3 A method of manufacturing according to claim 1 or 2, wherein X is a group having a uracil backbone, a group having a cytosine backbone, or a group having a thymine backbone that may have a substituent. Claim 4 A method of manufacturing according to claim 1 or 2, wherein X is a group having a uracil skeleton or a group having a cytosine skeleton that may have a substituent. Claim 5 A method of manufacture according to claim 1 or 2, wherein cyclopropanation is performed using the Simmons-Smith reaction. Claim 6 A method of preparation according to claim 1 or 2, wherein the compound represented by formula (II) is a compound selected from the following: Claim 7 A method for preparing a compound represented by the following formula (III), comprising at least a process of converting a compound represented by the following formula (II) into a cyclopropanol in the presence of an organic acid: (In the above formula (II), X represents a group having a purine skeleton that may have one or more any substituents selected from group α, wherein group α is composed of a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an alkylthio group having 1 to 5 carbon atoms, an amino group, an amino group protected by a protecting group for nucleic acid synthesis, an amino group substituted with an alkyl group having 1 to 5 carbon atoms, and a halogen atom; R 1 and R 2 Each independently comprises a hydrogen atom, a protecting group of a hydroxyl group in nucleic acid synthesis, an alkyl group having 1 to 7 carbon atoms that may form a branch or ring, an alkenyl group having 2 to 7 carbon atoms that may form a branch or ring, an aryl group having 3 to 10 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may have one or more substituents selected from group α and may include a heteroatom, an acyl group having one or more substituents selected from group α, a silyl group having one or more substituents selected from group α, a phosphate group having one or more substituents selected from group α, a phosphate group protected by a protecting group in nucleic acid synthesis, -P(R 3 )R 4 [In the middle of the meal, R 3 and R 4 [each independently represents a hydroxyl group, a hydroxyl group protected by a protecting group for nucleic acid synthesis, a mercapto group, a mercapto group protected by a protecting group for nucleic acid synthesis, an amino group, a C1–5 alkoxy group, a C1–5 alkylthio group, a C1–6 cyanoalkoxy group, or an amino group substituted with a C1–6 alkyl group;R 5 ...represents a hydrogen atom; a halogen atom; an alkyl group having 1 to 7 carbon atoms that may be substituted with an aryl group having 3 to 12 carbon atoms that may contain a heteroatom and may also form a branch or ring; an aralkyl group having an aryl portion having 3 to 12 carbon atoms that may contain a heteroatom; or a silyl group. (In the above equation (III), X, R 1 , R 2 and R 5 is as stated above, and R 5' is R 5 Independent of and R 5 Defined identically to ). Claim 8 delete Claim 9 delete Claim 10 delete Claim 11 delete Claim 12 delete Claim 13 delete Claim 14 delete Claim 15 delete Claim 16 delete Claim 17 delete Claim 18 delete Claim 19 delete Claim 20 delete Claim 21 delete Claim 22 delete Claim 23 delete Claim 24 delete Claim 25 delete Claim 26 delete Claim 27 delete Claim 28 delete Claim 29 delete Claim 30 delete

Citation Information

Patent Citations

  • 4'-c-ethynylpurine nucleoside compound

    JP2001335592A

  • 6-disubstituted bicyclic nucleic acid analogs

    WO2009006478A2